OPULENT PHARMA specialize in key areas like Organic Custom Synthesis & Chemical Development, and can offer chemical synthesis services of desired compounds from milligram to kg level. We are strong and currently focused in Pharmaceutical Impurity Synthesis but we also provide synthesis support for API, Pharmaceutical Intermediates, Specialty & Research Chemicals, Building Blocks & Library Synthesis, Custom Synthesis. We can offer more than 4000 Impurities (LIST ENCLOSED) from STOCK at an very competitive price, also feel free to share other requirements as the products we can offer are not limited to the list.
OPULENT PHARMA IMPURITY STOCK LIST (S-Z & MISCELLANEOUS)Opulent Pharma
This document lists impurity stock for various pharmaceutical products, including sotalol, sparfloxacin, stavudine, strontium ranelate, sulbactam, sulfadiazine, sulfadimidine, sulfamethoxazole, sulfasalazine, sulindac, sultamicillin, sumatriptan, sunitinib, tadalafil, tamsulosin, tasimelteon, telmisartan, temozolomide, and teneligliptin. For each product, several related impurities are listed along with their CAS numbers if available. Contact information is provided for inquiries.
The document is a list of impurities and related compounds for various pharmaceutical products, including metoprolol, metronidazole, milnacipran, minoxidil, mirabegron, and many others. It provides the chemical names and CAS registry numbers for each impurity compound. The list is from Opulent Pharma, an Indian company that offers impurity reference standards and custom synthesis support.
OPULENT PHARMA IMPURITY STOCK LIST (COMPLETE)Opulent Pharma
OPULENT PHARMA specialize in key areas like Organic Custom Synthesis & Chemical Development, and can offer chemical synthesis services of desired compounds from milligram to kg level. We are strong and currently focused in Pharmaceutical Impurity Synthesis but we also provide synthesis support for API, Pharmaceutical Intermediates, Specialty & Research Chemicals, Building Blocks & Library Synthesis, Custom Synthesis. We can offer more than 4000 Impurities (LIST ENCLOSED) from STOCK at an very competitive price, also feel free to share other requirements as the products we can offer are not limited to the list.
2024 State of Marketing Report – by HubspotMarius Sescu
https://www.hubspot.com/state-of-marketing
· Scaling relationships and proving ROI
· Social media is the place for search, sales, and service
· Authentic influencer partnerships fuel brand growth
· The strongest connections happen via call, click, chat, and camera.
· Time saved with AI leads to more creative work
· Seeking: A single source of truth
· TLDR; Get on social, try AI, and align your systems.
· More human marketing, powered by robots
ChatGPT is a revolutionary addition to the world since its introduction in 2022. A big shift in the sector of information gathering and processing happened because of this chatbot. What is the story of ChatGPT? How is the bot responding to prompts and generating contents? Swipe through these slides prepared by Expeed Software, a web development company regarding the development and technical intricacies of ChatGPT!
Product Design Trends in 2024 | Teenage EngineeringsPixeldarts
The realm of product design is a constantly changing environment where technology and style intersect. Every year introduces fresh challenges and exciting trends that mold the future of this captivating art form. In this piece, we delve into the significant trends set to influence the look and functionality of product design in the year 2024.
How Race, Age and Gender Shape Attitudes Towards Mental HealthThinkNow
Mental health has been in the news quite a bit lately. Dozens of U.S. states are currently suing Meta for contributing to the youth mental health crisis by inserting addictive features into their products, while the U.S. Surgeon General is touring the nation to bring awareness to the growing epidemic of loneliness and isolation. The country has endured periods of low national morale, such as in the 1970s when high inflation and the energy crisis worsened public sentiment following the Vietnam War. The current mood, however, feels different. Gallup recently reported that national mental health is at an all-time low, with few bright spots to lift spirits.
To better understand how Americans are feeling and their attitudes towards mental health in general, ThinkNow conducted a nationally representative quantitative survey of 1,500 respondents and found some interesting differences among ethnic, age and gender groups.
Technology
For example, 52% agree that technology and social media have a negative impact on mental health, but when broken out by race, 61% of Whites felt technology had a negative effect, and only 48% of Hispanics thought it did.
While technology has helped us keep in touch with friends and family in faraway places, it appears to have degraded our ability to connect in person. Staying connected online is a double-edged sword since the same news feed that brings us pictures of the grandkids and fluffy kittens also feeds us news about the wars in Israel and Ukraine, the dysfunction in Washington, the latest mass shooting and the climate crisis.
Hispanics may have a built-in defense against the isolation technology breeds, owing to their large, multigenerational households, strong social support systems, and tendency to use social media to stay connected with relatives abroad.
Age and Gender
When asked how individuals rate their mental health, men rate it higher than women by 11 percentage points, and Baby Boomers rank it highest at 83%, saying it’s good or excellent vs. 57% of Gen Z saying the same.
Gen Z spends the most amount of time on social media, so the notion that social media negatively affects mental health appears to be correlated. Unfortunately, Gen Z is also the generation that’s least comfortable discussing mental health concerns with healthcare professionals. Only 40% of them state they’re comfortable discussing their issues with a professional compared to 60% of Millennials and 65% of Boomers.
Race Affects Attitudes
As seen in previous research conducted by ThinkNow, Asian Americans lag other groups when it comes to awareness of mental health issues. Twenty-four percent of Asian Americans believe that having a mental health issue is a sign of weakness compared to the 16% average for all groups. Asians are also considerably less likely to be aware of mental health services in their communities (42% vs. 55%) and most likely to seek out information on social media (51% vs. 35%).
AI Trends in Creative Operations 2024 by Artwork Flow.pdfmarketingartwork
Creative operations teams expect increased AI use in 2024. Currently, over half of tasks are not AI-enabled, but this is expected to decrease in the coming year. ChatGPT is the most popular AI tool currently. Business leaders are more actively exploring AI benefits than individual contributors. Most respondents do not believe AI will impact workforce size in 2024. However, some inhibitions still exist around AI accuracy and lack of understanding. Creatives primarily want to use AI to save time on mundane tasks and boost productivity.
OPULENT PHARMA IMPURITY STOCK LIST (S-Z & MISCELLANEOUS)Opulent Pharma
This document lists impurity stock for various pharmaceutical products, including sotalol, sparfloxacin, stavudine, strontium ranelate, sulbactam, sulfadiazine, sulfadimidine, sulfamethoxazole, sulfasalazine, sulindac, sultamicillin, sumatriptan, sunitinib, tadalafil, tamsulosin, tasimelteon, telmisartan, temozolomide, and teneligliptin. For each product, several related impurities are listed along with their CAS numbers if available. Contact information is provided for inquiries.
The document is a list of impurities and related compounds for various pharmaceutical products, including metoprolol, metronidazole, milnacipran, minoxidil, mirabegron, and many others. It provides the chemical names and CAS registry numbers for each impurity compound. The list is from Opulent Pharma, an Indian company that offers impurity reference standards and custom synthesis support.
OPULENT PHARMA IMPURITY STOCK LIST (COMPLETE)Opulent Pharma
OPULENT PHARMA specialize in key areas like Organic Custom Synthesis & Chemical Development, and can offer chemical synthesis services of desired compounds from milligram to kg level. We are strong and currently focused in Pharmaceutical Impurity Synthesis but we also provide synthesis support for API, Pharmaceutical Intermediates, Specialty & Research Chemicals, Building Blocks & Library Synthesis, Custom Synthesis. We can offer more than 4000 Impurities (LIST ENCLOSED) from STOCK at an very competitive price, also feel free to share other requirements as the products we can offer are not limited to the list.
2024 State of Marketing Report – by HubspotMarius Sescu
https://www.hubspot.com/state-of-marketing
· Scaling relationships and proving ROI
· Social media is the place for search, sales, and service
· Authentic influencer partnerships fuel brand growth
· The strongest connections happen via call, click, chat, and camera.
· Time saved with AI leads to more creative work
· Seeking: A single source of truth
· TLDR; Get on social, try AI, and align your systems.
· More human marketing, powered by robots
ChatGPT is a revolutionary addition to the world since its introduction in 2022. A big shift in the sector of information gathering and processing happened because of this chatbot. What is the story of ChatGPT? How is the bot responding to prompts and generating contents? Swipe through these slides prepared by Expeed Software, a web development company regarding the development and technical intricacies of ChatGPT!
Product Design Trends in 2024 | Teenage EngineeringsPixeldarts
The realm of product design is a constantly changing environment where technology and style intersect. Every year introduces fresh challenges and exciting trends that mold the future of this captivating art form. In this piece, we delve into the significant trends set to influence the look and functionality of product design in the year 2024.
How Race, Age and Gender Shape Attitudes Towards Mental HealthThinkNow
Mental health has been in the news quite a bit lately. Dozens of U.S. states are currently suing Meta for contributing to the youth mental health crisis by inserting addictive features into their products, while the U.S. Surgeon General is touring the nation to bring awareness to the growing epidemic of loneliness and isolation. The country has endured periods of low national morale, such as in the 1970s when high inflation and the energy crisis worsened public sentiment following the Vietnam War. The current mood, however, feels different. Gallup recently reported that national mental health is at an all-time low, with few bright spots to lift spirits.
To better understand how Americans are feeling and their attitudes towards mental health in general, ThinkNow conducted a nationally representative quantitative survey of 1,500 respondents and found some interesting differences among ethnic, age and gender groups.
Technology
For example, 52% agree that technology and social media have a negative impact on mental health, but when broken out by race, 61% of Whites felt technology had a negative effect, and only 48% of Hispanics thought it did.
While technology has helped us keep in touch with friends and family in faraway places, it appears to have degraded our ability to connect in person. Staying connected online is a double-edged sword since the same news feed that brings us pictures of the grandkids and fluffy kittens also feeds us news about the wars in Israel and Ukraine, the dysfunction in Washington, the latest mass shooting and the climate crisis.
Hispanics may have a built-in defense against the isolation technology breeds, owing to their large, multigenerational households, strong social support systems, and tendency to use social media to stay connected with relatives abroad.
Age and Gender
When asked how individuals rate their mental health, men rate it higher than women by 11 percentage points, and Baby Boomers rank it highest at 83%, saying it’s good or excellent vs. 57% of Gen Z saying the same.
Gen Z spends the most amount of time on social media, so the notion that social media negatively affects mental health appears to be correlated. Unfortunately, Gen Z is also the generation that’s least comfortable discussing mental health concerns with healthcare professionals. Only 40% of them state they’re comfortable discussing their issues with a professional compared to 60% of Millennials and 65% of Boomers.
Race Affects Attitudes
As seen in previous research conducted by ThinkNow, Asian Americans lag other groups when it comes to awareness of mental health issues. Twenty-four percent of Asian Americans believe that having a mental health issue is a sign of weakness compared to the 16% average for all groups. Asians are also considerably less likely to be aware of mental health services in their communities (42% vs. 55%) and most likely to seek out information on social media (51% vs. 35%).
AI Trends in Creative Operations 2024 by Artwork Flow.pdfmarketingartwork
Creative operations teams expect increased AI use in 2024. Currently, over half of tasks are not AI-enabled, but this is expected to decrease in the coming year. ChatGPT is the most popular AI tool currently. Business leaders are more actively exploring AI benefits than individual contributors. Most respondents do not believe AI will impact workforce size in 2024. However, some inhibitions still exist around AI accuracy and lack of understanding. Creatives primarily want to use AI to save time on mundane tasks and boost productivity.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Our backs are like superheroes, holding us up and helping us move around. But sometimes, even superheroes can get hurt. That’s where slip discs come in.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
One health condition that is becoming more common day by day is diabetes.
According to research conducted by the National Family Health Survey of India, diabetic cases show a projection which might increase to 10.4% by 2030.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
Organizational culture includes values, norms, systems, symbols, language, assumptions, beliefs, and habits that influence employee behaviors and how people interpret those behaviors. It is important because culture can help or hinder a company's success. Some key aspects of Netflix's culture that help it achieve results include hiring smartly so every position has stars, focusing on attitude over just aptitude, and having a strict policy against peacocks, whiners, and jerks.
PEPSICO Presentation to CAGNY Conference Feb 2024Neil Kimberley
PepsiCo provided a safe harbor statement noting that any forward-looking statements are based on currently available information and are subject to risks and uncertainties. It also provided information on non-GAAP measures and directing readers to its website for disclosure and reconciliation. The document then discussed PepsiCo's business overview, including that it is a global beverage and convenient food company with iconic brands, $91 billion in net revenue in 2023, and nearly $14 billion in core operating profit. It operates through a divisional structure with a focus on local consumers.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Our backs are like superheroes, holding us up and helping us move around. But sometimes, even superheroes can get hurt. That’s where slip discs come in.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
One health condition that is becoming more common day by day is diabetes.
According to research conducted by the National Family Health Survey of India, diabetic cases show a projection which might increase to 10.4% by 2030.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Travel vaccination in Manchester offers comprehensive immunization services for individuals planning international trips. Expert healthcare providers administer vaccines tailored to your destination, ensuring you stay protected against various diseases. Conveniently located clinics and flexible appointment options make it easy to get the necessary shots before your journey. Stay healthy and travel with confidence by getting vaccinated in Manchester. Visit us: www.nxhealthcare.co.uk
Organizational culture includes values, norms, systems, symbols, language, assumptions, beliefs, and habits that influence employee behaviors and how people interpret those behaviors. It is important because culture can help or hinder a company's success. Some key aspects of Netflix's culture that help it achieve results include hiring smartly so every position has stars, focusing on attitude over just aptitude, and having a strict policy against peacocks, whiners, and jerks.
PEPSICO Presentation to CAGNY Conference Feb 2024Neil Kimberley
PepsiCo provided a safe harbor statement noting that any forward-looking statements are based on currently available information and are subject to risks and uncertainties. It also provided information on non-GAAP measures and directing readers to its website for disclosure and reconciliation. The document then discussed PepsiCo's business overview, including that it is a global beverage and convenient food company with iconic brands, $91 billion in net revenue in 2023, and nearly $14 billion in core operating profit. It operates through a divisional structure with a focus on local consumers.
Content Methodology: A Best Practices Report (Webinar)contently
This document provides an overview of content methodology best practices. It defines content methodology as establishing objectives, KPIs, and a culture of continuous learning and iteration. An effective methodology focuses on connecting with audiences, creating optimal content, and optimizing processes. It also discusses why a methodology is needed due to the competitive landscape, proliferation of channels, and opportunities for improvement. Components of an effective methodology include defining objectives and KPIs, audience analysis, identifying opportunities, and evaluating resources. The document concludes with recommendations around creating a content plan, testing and optimizing content over 90 days.
How to Prepare For a Successful Job Search for 2024Albert Qian
The document provides guidance on preparing a job search for 2024. It discusses the state of the job market, focusing on growth in AI and healthcare but also continued layoffs. It recommends figuring out what you want to do by researching interests and skills, then conducting informational interviews. The job search should involve building a personal brand on LinkedIn, actively applying to jobs, tailoring resumes and interviews, maintaining job hunting as a habit, and continuing self-improvement. Once hired, the document advises setting new goals and keeping skills and networking active in case of future opportunities.
A report by thenetworkone and Kurio.
The contributing experts and agencies are (in an alphabetical order): Sylwia Rytel, Social Media Supervisor, 180heartbeats + JUNG v MATT (PL), Sharlene Jenner, Vice President - Director of Engagement Strategy, Abelson Taylor (USA), Alex Casanovas, Digital Director, Atrevia (ES), Dora Beilin, Senior Social Strategist, Barrett Hoffher (USA), Min Seo, Campaign Director, Brand New Agency (KR), Deshé M. Gully, Associate Strategist, Day One Agency (USA), Francesca Trevisan, Strategist, Different (IT), Trevor Crossman, CX and Digital Transformation Director; Olivia Hussey, Strategic Planner; Simi Srinarula, Social Media Manager, The Hallway (AUS), James Hebbert, Managing Director, Hylink (CN / UK), Mundy Álvarez, Planning Director; Pedro Rojas, Social Media Manager; Pancho González, CCO, Inbrax (CH), Oana Oprea, Head of Digital Planning, Jam Session Agency (RO), Amy Bottrill, Social Account Director, Launch (UK), Gaby Arriaga, Founder, Leonardo1452 (MX), Shantesh S Row, Creative Director, Liwa (UAE), Rajesh Mehta, Chief Strategy Officer; Dhruv Gaur, Digital Planning Lead; Leonie Mergulhao, Account Supervisor - Social Media & PR, Medulla (IN), Aurelija Plioplytė, Head of Digital & Social, Not Perfect (LI), Daiana Khaidargaliyeva, Account Manager, Osaka Labs (UK / USA), Stefanie Söhnchen, Vice President Digital, PIABO Communications (DE), Elisabeth Winiartati, Managing Consultant, Head of Global Integrated Communications; Lydia Aprina, Account Manager, Integrated Marketing and Communications; Nita Prabowo, Account Manager, Integrated Marketing and Communications; Okhi, Web Developer, PNTR Group (ID), Kei Obusan, Insights Director; Daffi Ranandi, Insights Manager, Radarr (SG), Gautam Reghunath, Co-founder & CEO, Talented (IN), Donagh Humphreys, Head of Social and Digital Innovation, THINKHOUSE (IRE), Sarah Yim, Strategy Director, Zulu Alpha Kilo (CA).
Trends In Paid Search: Navigating The Digital Landscape In 2024Search Engine Journal
The search marketing landscape is evolving rapidly with new technologies, and professionals, like you, rely on innovative paid search strategies to meet changing demands.
It’s important that you’re ready to implement new strategies in 2024.
Check this out and learn the top trends in paid search advertising that are expected to gain traction, so you can drive higher ROI more efficiently in 2024.
You’ll learn:
- The latest trends in AI and automation, and what this means for an evolving paid search ecosystem.
- New developments in privacy and data regulation.
- Emerging ad formats that are expected to make an impact next year.
Watch Sreekant Lanka from iQuanti and Irina Klein from OneMain Financial as they dive into the future of paid search and explore the trends, strategies, and technologies that will shape the search marketing landscape.
If you’re looking to assess your paid search strategy and design an industry-aligned plan for 2024, then this webinar is for you.
5 Public speaking tips from TED - Visualized summarySpeakerHub
From their humble beginnings in 1984, TED has grown into the world’s most powerful amplifier for speakers and thought-leaders to share their ideas. They have over 2,400 filmed talks (not including the 30,000+ TEDx videos) freely available online, and have hosted over 17,500 events around the world.
With over one billion views in a year, it’s no wonder that so many speakers are looking to TED for ideas on how to share their message more effectively.
The article “5 Public-Speaking Tips TED Gives Its Speakers”, by Carmine Gallo for Forbes, gives speakers five practical ways to connect with their audience, and effectively share their ideas on stage.
Whether you are gearing up to get on a TED stage yourself, or just want to master the skills that so many of their speakers possess, these tips and quotes from Chris Anderson, the TED Talks Curator, will encourage you to make the most impactful impression on your audience.
See the full article and more summaries like this on SpeakerHub here: https://speakerhub.com/blog/5-presentation-tips-ted-gives-its-speakers
See the original article on Forbes here:
http://www.forbes.com/forbes/welcome/?toURL=http://www.forbes.com/sites/carminegallo/2016/05/06/5-public-speaking-tips-ted-gives-its-speakers/&refURL=&referrer=#5c07a8221d9b
ChatGPT and the Future of Work - Clark Boyd Clark Boyd
Everyone is in agreement that ChatGPT (and other generative AI tools) will shape the future of work. Yet there is little consensus on exactly how, when, and to what extent this technology will change our world.
Businesses that extract maximum value from ChatGPT will use it as a collaborative tool for everything from brainstorming to technical maintenance.
For individuals, now is the time to pinpoint the skills the future professional will need to thrive in the AI age.
Check out this presentation to understand what ChatGPT is, how it will shape the future of work, and how you can prepare to take advantage.
The document provides career advice for getting into the tech field, including:
- Doing projects and internships in college to build a portfolio.
- Learning about different roles and technologies through industry research.
- Contributing to open source projects to build experience and network.
- Developing a personal brand through a website and social media presence.
- Networking through events, communities, and finding a mentor.
- Practicing interviews through mock interviews and whiteboarding coding questions.
Google's Just Not That Into You: Understanding Core Updates & Search IntentLily Ray
1. Core updates from Google periodically change how its algorithms assess and rank websites and pages. This can impact rankings through shifts in user intent, site quality issues being caught up to, world events influencing queries, and overhauls to search like the E-A-T framework.
2. There are many possible user intents beyond just transactional, navigational and informational. Identifying intent shifts is important during core updates. Sites may need to optimize for new intents through different content types and sections.
3. Responding effectively to core updates requires analyzing "before and after" data to understand changes, identifying new intents or page types, and ensuring content matches appropriate intents across video, images, knowledge graphs and more.
A brief introduction to DataScience with explaining of the concepts, algorithms, machine learning, supervised and unsupervised learning, clustering, statistics, data preprocessing, real-world applications etc.
It's part of a Data Science Corner Campaign where I will be discussing the fundamentals of DataScience, AIML, Statistics etc.
Time Management & Productivity - Best PracticesVit Horky
Here's my presentation on by proven best practices how to manage your work time effectively and how to improve your productivity. It includes practical tips and how to use tools such as Slack, Google Apps, Hubspot, Google Calendar, Gmail and others.
The six step guide to practical project managementMindGenius
The six step guide to practical project management
If you think managing projects is too difficult, think again.
We’ve stripped back project management processes to the
basics – to make it quicker and easier, without sacrificing
the vital ingredients for success.
“If you’re looking for some real-world guidance, then The Six Step Guide to Practical Project Management will help.”
Dr Andrew Makar, Tactical Project Management
Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...Applitools
During this webinar, Anand Bagmar demonstrates how AI tools such as ChatGPT can be applied to various stages of the software development life cycle (SDLC) using an eCommerce application case study. Find the on-demand recording and more info at https://applitools.info/b59
Key takeaways:
• Learn how to use ChatGPT to add AI power to your testing and test automation
• Understand the limitations of the technology and where human expertise is crucial
• Gain insight into different AI-based tools
• Adopt AI-based tools to stay relevant and optimize work for developers and testers
* ChatGPT and OpenAI belong to OpenAI, L.L.C.
The document discusses various AI tools from OpenAI like GPT-3 and DALL-E 2, as well as ChatGPT. It explores how search engines are using AI and things to consider around AI-generated content. Potential SEO uses of ChatGPT are also presented, such as generating content at scale, conducting topic research, and automating basic coding tasks. The document encourages further reading on using ChatGPT for SEO purposes.
More than Just Lines on a Map: Best Practices for U.S Bike Routes
This session highlights best practices and lessons learned for U.S. Bike Route System designation, as well as how and why these routes should be integrated into bicycle planning at the local and regional level.
Presenters:
Presenter: Kevin Luecke Toole Design Group
Co-Presenter: Virginia Sullivan Adventure Cycling Association
Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...DevGAMM Conference
Has your project been caught in a storm of deadlines, clashing requirements, and the need to change course halfway through? If yes, then check out how the administration team navigated through all of this, relocating 160 people from 3 countries and opening 2 offices during the most turbulent time in the last 20 years. Belka Games’ Chief Administrative Officer, Katerina Rudko, will share universal approaches and life hacks that can help your project survive unstable periods when there seem to be too many tasks and a lack of time and people.
7.
Erythromycin EP Impurity B/ Erythromycin Related Compund N (Clarithromycin EP Impurity R/ N‐Desmethyl 6‐O‐
Desmethyl Clarithromycin/ N‐Desmethyl Erythromycin A) 992‐62‐1
Erythromycin EP impurity C (Erythromycin E) 41451‐91‐6
Erythromycin EP Impurity D (Anhydro Erythromycin A) 23893‐13‐2
Erythromycin EP Impurity E (Erythromycin A Enol ether) 33396‐29‐1
Erythromycin EP Impurity F (Pseudo Erythromycin A Enol Ether) 105882‐69‐7
Erythromycin EP Impurity H (Erythromycin A N‐oxide) 992‐65‐4
Erythromycin EP Impurity I (Erythralosamine) 546‐57‐6
Erythromycin EP Impurity L (N‐Formyl Erythromycin A) 127955‐44‐6
9‐Deoxo‐9a‐aza‐9a‐homo Erythromycin A (Azithromycin EP Impurity A/ N6‐Demethylazithromycin/
Desmethylazithromycin/ Azaerythromycin A/ Azathramycin) 76801‐85‐9
Erythromycin Oxime (Azithromycin Impurity S/ 9‐Erythromycin A Oxime/ Roxithromycin Impurity C/ Clarithromycin EP
Impurity J) 13127‐18‐9
Erythromycin A 9,11‐Imino Ether (Azithromycin Impurity R) 161193‐44‐8
Erythromycin A 6,9‐Imino Ether (Azithromycin Iminoether impurity) 99290‐97‐8
Product: ESCITALOPRAM IMPURITIES
EsCitalopram EP Impurity A (Citalopram EP Impurity A/ Citalopram Related Compound A/ Citalopram Amide) 64372‐56‐1
EsCitalopram EP Impurity D (Citalopram EP Impurity D/ Citalopram Related Compound D/ N‐Desmethyl Citalopram)
62498‐67‐3
97743‐99‐2
1188264‐72‐3
Escitalopram EP Impurity E/ Escitalopram Related Compound A (Citadiol/ Citalopram Dihydroxy Impurity)
103146‐25‐4
103146‐26‐5
128173‐53‐5
EsCitalopram EP Impurity F
Escitalopram EP Impurity G (Citalopram Dimethylaminobutanone/ Citalopram EP Impurity G/ Citalopram ketone) 1329745‐98‐3
Escitalopram EP Impurity H (Citalopram Related Compound E/ Citalopram N‐Oxide) 63284‐72‐0
EsCitalopram EP Impurity K (Citalopram R‐Isomer)
219861‐53‐7
128196‐02‐1
8.
EsCitalopram EP Impurity L (Citalopram Desfluoro Impurity) 1346617‐30‐8
EsCitalopram EP Impurity M (Citalopram Carboxylic Acid Impurity/ Descyano Citalopram Carboxylic Acid) 440121‐09‐5
5‐Bromophthalide 64169‐34‐2
1,3‐dihydro‐1‐oxoisobenzofuran‐5‐carboxamide 85118‐25‐8
Escitalopram Impurity E ((S)‐Citalopram Fluorophenylmethanone Impurity)
1217846‐84‐8
1217846‐85‐9
Product: ESLICARBAZEPINE IMPURITIES
Oxcarbazepine 28721‐07‐5
Licarbazepine 29331‐92‐8
Eslicarbazepine Acetate R Isomer/ (R)‐Licarbazepine Acetate 186694‐45‐1
Product: ESOMEPRAZOLE IMPURITIES
Esomeprazole EP Impurity A (Omeprazole EP Impurity A/ Omeprazole Related Compound B) 37052‐78‐1
Esomeprazole EP Impurity B (Omeprazole EP Impurity B/ Desmethoxy Omeprazole) 110374‐16‐8
Esomeprazole EP Impurity C (Omeprazole EP Impurity C/ Omeprazole Sulfide/ Ufiprazole) 73590‐85‐9
Esomeprazole EP Impurity D/ Esomeprazole Related Compound A (Omeprazole EP Impurity D/ Omeprazole Sulfone) 88546‐55‐8
Esomeprazole EP Impurity E (Omeprazole EP Impurity E/ Omeprazole Related Compound E/ Omeprazole N‐Oxide) 176219‐04‐8
Esomeprazole EP Impurity F (Omeprazole R‐Isomer)
119141‐89‐8
161796‐77‐6
Esomeprazole Impurity H (Omeprazole EP Impurity H) 863029‐89‐4
Esomeprazole Impurity Sulfone N‐Oxide (Omeprazole EP Impurity I/ Omeprazole Related Compound I/ Omeprazole
Sulfone N‐Oxide) 158812‐85‐2
Product: ESTRADIOL IMPURITIES
Estradiol EP Impurity A (Estriol EP Impurity B/ Ethinylestradiol EP Impurity C/ Estrone) 53‐16‐7
Product: ESTRIOL IMPURITIES
9.
Estriol EP Impurity B (Ethinylestradiol EP Impurity C/ Estradiol EP Impurity A/ Estrone) 53‐16‐7
Estriol EP Impurity D (Ethinylestradiol EP Impurity D/ Estradiol) 50‐28‐2
Product: ESZOPICLONE IMPURITIES
Eszopiclone Impurity C 148891‐53‐6
N‐Demethyl Eszopiclone
151776‐26‐0
300701‐71‐7
Product: ETHACRYNIC IMPURITIES
Ethacrynic Acid impurity A 1217‐67‐0
Ethacrynic Acid impurity B 95772‐54‐6
Product: ETHAMBUTOL IMPURITIES
Ethambutol EP Impurity A 96‐20‐8
Product: ETHINYLESTRADIOL IMPURITIES
Ethinylestradiol EP Impurity B/ Ethinyl Estradiol Related Compound B 1231‐96‐5
Ethinylestradiol EP Impurity C (Estriol EP Impurity B/ Estradiol EP Impurity A/ Estrone) 53‐16‐7
Ethinylestradiol EP Impurity D (Estriol EP Impurity D/ Estradiol) 50‐28‐2
Product: ETHIONAMIDE IMPURITIES
Ethionamide EP Impurity A 2196‐13‐6
Ethionamide EP Impurity B 100‐48‐1
Product: ETILEFRINE IMPURITIES
Etilefrine EP Impurity E 121‐71‐1
Product: ETODOLAC IMPURITIES
Etodolac EP Impurity A (8‐Desethyl Etodolac) 41339‐67‐7
Etodolac EP Impurity B (8‐Methyl Etodolac) 41340‐19‐6
Etodolac EP Impurity C/ Etodolac Related Compound A (1‐Methyl Etodolac) 109518‐50‐5
Etodolac EP Impurity J (Decarboxy Etodolac) 115066‐03‐0
Etodolac Impurity H (7‐Ethyltryptophol) 41340‐36‐7
3‐Oxopentanoic Acid 10191‐25‐0
2‐Ethylphenylhydrazine hydrochloride 19398‐06‐2
11.
Product: FAMCICLOVIR IMPURITIES
Famciclovir Related Compound A (6‐Deoxypenciclovir) 104227‐86‐3
Famciclovir Related Compound B (6‐Deoxypenciclovir Acetate/ Desacetyl Famciclovir) 104227‐88‐5
Famciclovir Related Compound E (2‐Aminopurine)
452‐06‐2
76124‐64‐6
Famciclovir Related Compound F 10310‐21‐1
Famciclovir Deoxy‐chloro Impurity
Famciclovir Dimethylaminopyridine Impurity (Valaciclovir EP Impurity G/ Valaciclovir Related Compound G) 1122‐58‐3
Product: FAMOTIDINE IMPURITIES
Famotidine EP Impurity A/ Famotidine Related Compound A 76833‐47‐1
Famotidine EP Impurity B/ Famotidine Related Compound B 89268‐62‐2
Famotidine EP Impurity C/ Famotidine Related Compound C
106433‐44‐7
76824‐17‐4
Famotidine EP Impurity D/ Famotidine Related Compound D 76824‐16‐3
Famotidine EP Impurity E/ Famotidine Related Compound E 129083‐44‐9
Famotidine EP Impurity F/ Famotidine Related Compound F (Famotidine Acid Impurity) 107880‐74‐0
Famotidine EP Impurity H (Famotidine Isothiourea Impurity)
106649‐96‐1
88046‐01‐9
Famotidine EP Impurity I 1020719‐36‐1
Famotidine EP Impurity J (Famotidine Acid Methyl Ester)
76824‐14‐1
1798006‐30‐0
Famotidine Related Compound A
124646‐10‐2
88061‐72‐7
Famotidine cyclic Impurity
Famotidine Sulfoxide 90237‐03‐9
Product: FEBANTEL IMPURITIES
1‐Nitro Febantel (Fenbendazole F‐1 compound) 63470‐85‐9
Product: FEBENDAZOLE IMPURITIES
Fenbendazole F‐1 compound (1‐Nitro Febantel) 63470‐85‐9
12.
Product: FEBUXOSTAT IMPURITIES
Febuxostat Dicarboxylic Acid Impurity 1239233‐87‐4
Febuxostat Amide Impurity 1239233‐86‐3
4‐Cyanophenol 767‐00‐0
Febuxostat Descyano Hydroxy Ethyl Ester 161797‐99‐5
Ethyl 2‐(3‐formyl‐4‐isobutoxyphenyl)‐4‐methylthiazole‐5‐carboxylate 161798‐03‐4
Febuxostat Ethyl Ester 160844‐75‐7
Febuxostat 4‐Hydroxy Ethyl Ester 161798‐02‐3
Ferbuxostat Diethyl Ester Impurity 1643131‐93‐4
Febuxostat Acid Ester Impurity 2095166‐41‐7
Febuxostat sec‐Butyl Ether Acid Impurity 1335202‐59‐9
Febuxostat Butyl Ether Analog 1657014‐33‐9
Febuxostat Isopropyl Ether Analog 144060‐52‐6
Product: FELBAMATE IMPURITIES
Phenylpropanediol 1570‐95‐2
Product: FELBINAC IMPURITIES
Felbinac EP Impurity A (4‐Acetyl biphenyl) 92‐91‐1
Felbinac EP Impurity B (Fenbufen EP Impurity C/ Biphenyl ) 92‐52‐4
Product: FELODIPINE IMPURITIES
Felodipine EP Impurity A (Dehydro Felodipine) 96382‐71‐7
Felodipine EP Impurity B (Felodipine Dimethyl Ester) 91189‐59‐2
Felodipine EP Impurity C (Felodipine Diethyl Ester/ Nemadipine B) 79925‐38‐5
Product: FENBUFEN IMPURITIES
Fenbufen EP Impurity C (Felbinac EP Impurity B/ Biphenyl ) 92‐52‐4
Product: FENOFIBRATE IMPURITIES
Fenofibrate EP Impurity A/ Fenofibrate Related Compound A 42019‐78‐3
Fenofibrate EP Impurity B/ Fenofibrate Related Compound B (Fenofibric Acid) 42017‐89‐0
Fenofibrate EP Impurity C 217636‐47‐0
Fenofibrate EP Impurity D (Fenofibrate Methyl Ester Analog) 42019‐07‐8
Fenofibrate EP Impurity E (Fenofibrate Ethyl Ester Analog) 42019‐08‐9
13.
Fenofibrate EP Impurity F 154356‐96‐4
Fenofibrate EP Impurity G/ Fenofibrate Related Compound C 217636‐48‐1
Fenofibric Acid 1‐Carboxyl‐1‐methylethyl Ester 1797121‐54‐0
Choline Fenofibrate 856676‐23‐8
Product: FENTANYL IMPURITIES
Ethyl (2‐Amino‐4‐thiazolyl)acetate 53266‐94‐7
Product: FENTICONAZOLE IMPURITIES
Fenticonazole EP Impurity A (Econazole EP Impurity A/ Econazole Related Compound A/ Miconazole EP Impurity A/
Deschlorobenzyl Econazole/ Tioconazole EP Impurity D/ Isoconazole EP Impurity B/ Isoconazole Nitrate EP Impurity A) 24155‐42‐8
Product: FESOTERODINE IMPURITIES
3‐(3‐Aminopropyl)benzoic Acid 1346604‐68‐9
Fesoterodine Fumarate Ester 1254942‐29‐4
Fesoterodine O‐Isobutyryl Impurity 1208313‐13‐6
Fesoterodine Diol (R)‐Isomer (Tolterodine 5‐Hydroxymethyl Analog (R)‐Isomer) 207679‐81‐0
Fesoterodine Isobutyrate Aldehyde Impurity 1435768‐96‐9
(S)‐3‐(3‐(diisopropylamino)‐1‐phenylpropyl)‐4‐hydroxybenzaldehyde 214601‐12‐4
Product: FEXOFENADINE HYDROCHLORIDE IMPURITIES
Fexofenadine EP Impurity A/ Fexofenadine Related Compound A (Fexofenadinone) 76811‐98‐8
Fexofenadine EP Impurity B/ Fexofenadine Related Compound B (Meta‐Fexofenadine) 479035‐75‐1
Fexofenadine EP Impurity C/ Fexofenadine Related Compound C (Decarboxy Fexofenadine) 185066‐37‐9
Fexofenadine EP Impurity D (Fexofenadine Methyl Ester) 154825‐96‐4
Fexofenadine EP Impurity E 115‐46‐8
Fexofenadine EP Impurity G 1187954‐57‐9
Fexofenadine Keto ester/ 1‐Oxo Fexofenadine Methyl Ester
154477‐55‐1
169280‐33‐5
Fexofenadine Cyclopropyl acid Impurity 162096‐54‐0
Benzene aceticacid,4‐(4‐hydroxy‐1‐oxobutyl)‐alpha,alpha‐dimethyl‐,methylester 394222‐30‐1
Fexofenadine Impurity D/ 4‐[4‐[4‐(Hydroxydiphenylmethyl)‐1‐piperidinyl]‐1‐butyn‐1‐yl]‐α,α‐dimethyl‐benzeneacetic
Acid 832088‐68‐3
4‐(4‐Chloro‐1‐oxobutyl)‐α,α‐dimethylbenzeneacetic Acid Methyl Ester 154477‐54‐0
Product: FINASTERIDE IMPURITIES
14.
Finasteride EP Impurity A/ Finasteride Related Compund A (1,2‐Dihydro Finasteride) 98319‐24‐5
Finasteride EP Impurity B/ Finasteride Related Compund D (Dutasteride Methyl Ester Analog/Finasteride Methyl Ester
Analog) 103335‐41‐7
Finasteride EP Impurity C/ Finasteride Related Compund B (5,6‐Dehydro Finasteride) 1329611‐51‐9
5β‐Finasteride 140375‐22‐0
Finasteride Dihydro Carboxylic Acid 103335‐55‐3
Product: FINGOLIMOD IMPURITIES
Fingolimod Palmitate Amide 1242271‐26‐6
Fingolimod sterate Amide 1242271‐27‐7
Fingolimod mono O‐Acetyl 1807973‐92‐7
Fingolimod Decyl Impurity (Fingolimod C10 Homolog) 780729‐32‐0
2‐(4‐Decylphenethyl)‐2‐nitropropane‐1,3‐diol
1‐(4‐Decylphenyl)‐3‐nitropropan‐1one
Fingolimod Hexyl Impurity (Fingolimod C6 Homolog) 1201794‐93‐5
2‐(4‐hexylphenethyl)‐2‐nitropropane‐1,3‐diol
1‐(4‐hexylphenyl)‐3‐nitropropan‐1‐one
3‐Nitro‐1‐(4‐octylphenyl)propan‐1‐one 899822‐97‐0
Triacetylated Fingolimod 162358‐09‐0
1‐(4‐heptylphenyl)‐3‐nitropropan‐1‐one
Fingolimod Heptyl Analog
745767‐97‐9
162361‐44‐6
Vinyl Fingolimod 24993‐87‐1
Fingolimod EP Impurity E (Fingolimod ortho‐octylphenyl Impurity/ Fingolimod 2‐Phenethyl Analog) 851039‐25‐3
Fingolimod EP Impurity F Fingolimod meta‐octylphenyl Impurity/ Fingolimod 3‐Phenethyl Analog) 851039‐24‐2
Fingolimod Deshydroxymethyl N‐Acetyl Impurity 177259‐52‐8
Fingolimod Nitro Impurity 374077‐88‐0
Fingolimod N,N‐Dimethyl Impurity 1404433‐87‐9
Fingolimod N‐Methyl Impurity 1404233‐80‐2
15.
Fingolimod Nonyl Impurity/ Fingolimod C9 Homolog 296282‐40‐1
Fingolimod 4‐Hydroxy Impurity 268557‐51‐3
N‐Ethyl Fingolimod 1402793‐28‐5
Fingolimod Methyl Impurity 162361‐47‐9
Fingolimod Impurity C 296282‐46‐7
Fingolimod 1‐Hydroxy Nitro Impurity 899822‐99‐2
Fingolimod EP Impurity I 249289‐10‐9
Fingolimod N‐Acetyl Diethyl Ester 162358‐08‐9
Fingolimod EP Impurity C 746594‐44‐5
2‐acetamido‐2‐phenethyl‐propanedioate 5463‐92‐3
n‐Octylbenzene 2189‐60‐8
4'‐n‐Octylacetophenone 10541‐56‐7
4’‐Deoctyl 4’‐(1‐Hydroxyoctyl) Fingolimod 296282‐43‐4
1‐(3‐nitropropyl)‐4‐octylbenzene 374077‐87‐9
Product: FLAVOXATE IMPURITIES
Flavoxate EP Impurity A/ Flavoxate Related Compound A 3468‐01‐7
Flavoxate EP Impurity B/ Flavoxate Related Compound C 35888‐94‐9
Flavoxate EP Impurity C 1286165‐14‐7
Product: FLECAINIDE IMPURITIES
Flecainide EP Impurity B 22990‐77‐8
Flecainide EP Impurity D 35480‐52‐5
Flecainide EP Impurity E 57415‐36‐8
Flecainide Related Compound A
Product: FLUCLOXACILLIN IMPURITIES
Flucloxacillin EP Impurity B (Flucloxacillin Penilloic Acid) 1276016‐89‐7
Flucloxacillin EP Impurity C (Cloxacillin EP Impurity C/ Ampicillin EP Impurity A/ Amoxicillin EP Impurity A/ Amoxicillin
Related Compound A/ Piperacillin EP Impurity H/ Sulbactam EP Impurity B/ 6‐Aminopenicillanic Acid) 551‐16‐6
(5R)‐Flucloxacillin Penilloic Acid 42947‐70‐6
Product: FLUCONAZOLE IMPURITIES
16.
Fluconazole EP Impurity A (Fluconazole Triazole Isomer) 89429‐59‐4
Fluconazole EP Impurity B/ Fluconazole Related Compound A 871550‐15‐1
Fluconazole EP Impurity C/ Fluconazole Related Compound C 514222‐44‐7
Fluconazole EP Impurity D/ Fluconazole Related Compound B (2‐Desfluoro Fluconazole) 81886‐51‐3
Fluconazole EP Impurity E (Fluconazole Keto Impurity/ Voriconazole EP Impurity A/ Voriconazole Related Compound C/
Voriconazole Triazole Acetophenone Impurity) 86404‐63‐9
Fluconazole EP Impurity F (Fluconazole Diol Impurity) 118689‐07‐9
Fluconazole EP Impurity G (Fluconazole Epoxide Impurity) 86386‐76‐7
Fluconazole EP Impurity H (Fluconazole Bromo Impurity) 150194‐52‐8
Fluconazole Impurity 5 154534‐83‐5
Product: FLUDARABINE IMPURITIES
Fludarabine Phosphate EP Impurity D 700‐49‐2
Product: FLUNARIZINE IMPURITIES
Flunarizine EP Impurity A 27469‐60‐9
Flunarizine EP Impurity B 27064‐96‐6
Product: FLUOROURACIL IMPURITIES
Fluorouracil EP Impurity A (Barbituric acid) 67‐52‐7
Fluorouracil EP Impurity B (Isobarbituric acid) 496‐76‐4
Fluorouracil EP Impurity C (Lamivudine EP Impurity F/ Uracil) 66‐22‐8
Fluorouracil EP Impurity D (5‐Methoxyuracil) 6623‐81‐0
Fluorouracil EP Impurity E (5‐Chlorouracil) 1820‐81‐1
Product: FLUOXETINE IMPURITIES
Fluoxetine EP Impurity A 42142‐52‐9
Fluoxetine EP Impurity B/ Fluoxetine Related Compound B
30684‐07‐2
23580‐89‐4
Fluoxetine Related Compound A (Meta Fluoxetine/ Fluoxetine Impurity C)
56161‐72‐9
79088‐29‐2
Fluoxetine related compound C (Fluoxetine Succinamic Acid) 1026723‐45‐4
17.
N‐Formylfluoxetine 199188‐97‐1
p‐Nitrobenzal Difluoride 29848‐57‐5
N‐methyl‐3‐phenylprop‐2‐en‐1‐amine 60960‐88‐5
Fluoxetine N‐β‐D‐Glucuronide 96735‐71‐6
Product: FLUPIRTINE IMPURITIES
Flupirtine Desfluoro Impurity
736866‐91‐4
21630‐56‐8
Flupirtine Impurity C/ 2‐Amino‐6‐(benzylamino)‐3‐nitropyridine 21626‐43‐7
Flupirtine Maleate Impurity A/ Flupirtine 2‐Oxo Impurity 951624‐49‐0
Product: FLUPROSTENOL IMPURITIES
15‐keto Fluprostenol isopropyl ester 404830‐45‐1
Product: FLURBIPROFEN IMPURITIES
Flurbiprofen EP Impurity A (Biprofen) 6341‐72‐6
Flurbiprofen EP Impurity B 1797883‐74‐9
Methyl Flurbiprofen 66202‐86‐6
Product: FLUTAMIDE IMPURITIES
Flutamide EP Impurity C 13312‐12‐4
Flutamide EP Impurity E 1939‐27‐1
Product: FLUTICASONE IMPURITIES
Fluticasone EP Impurity A (Fluticasone Carboxylic Acid Propionate) 65429‐42‐7
Fluticasone EP impurity B/ Fluticasone Related Compound A (Fluticasone Sulfenic Acid Propionate) 948566‐12‐9
Fluticasone EP Impurity C/ Fluticasone Related Compound C (Fluticasone Acetate Analog) 80474‐24‐4
Fluticasone EP Impurity D/ Fluticasone Related Compound D (Fluticasone Methylsulphanyl Analog/ Ticabesone
Propionate) 73205‐13‐7
Fluticasone EP Impurity F (11‐Oxo Fluticasone Propionate) 1219174‐94‐3
Fluticasone EP Impurity G/ Fluticasone Related Compound E (Fluticasone Dimer Impurity) 220589‐37‐7
Fluticasone Related Compound B (Fluticasone Trioxo Impurity) 219719‐95‐6
19.
Fosfomycin EP Impurity C
23001‐39‐0
114252‐50‐5
Product: FOSINOPRIL IMPURITIES
Fosinopril EP Impurity A/ Fosinopril Related Compound A (Fosinoprilat) 95399‐71‐6
Product: FROVATRIPTAN IMPURITIES
Frovatriptan 3‐Hydrazinylbenzamide Impurity/ Frovatriptan Impurity 5 473927‐51‐4
4‐hydrazinylbenzamide 74885‐67‐9
1,4‐Cyclohexanedione mono(2,2‐dimethyltrimethylene ketal) 69225‐59‐8
Frovatriptan Impurity 6/ 3,3,12,12‐Tetramethyl‐1,5,10,14‐tetraoxadispiro[5.2.5.2]hexadecane 29280‐23‐7
Frovatriptan Impurity 8 / N,N,3,3‐Tetramethyl‐1,5‐dioxaspiro[5.5]undecan‐9‐amine 107431‐14‐1
4‐(Methylamino)cyclohexanone 2,2‐Dimethyltrimethylene Ketal Hydrochloride 158747‐10‐5
Product: FULVESTRANT IMPURITIES
Fulvestrant Int‐TBDMS chain 149051‐24‐1
Fulvestrant Side chain impurity 148757‐89‐5
3‐O‐Methyl Fulvestrant 1221256‐46‐7
Fulvestrant EP Impurity A (7β‐Fulvestrant) 407577‐53‐1
S‐Deoxo Fulvestrant 153004‐31‐0
Product: FUROSEMIDE IMPURITIES
Furosemide EP Impurity A/ Furosemide Related Compound A (Iso Furosemide) 4818‐59‐1
Furosemide EP Impurity B 2736‐23‐4
Furosemide EP Impurity C/ Furosemide Related Compound B (Saluamine) 3086‐91‐7
Furosemide EP Impurity D 5046‐19‐5
Furosemide EP Impurity E 50‐84‐0
Furosemide EP Impurity F (Tetrahydro Furosemide) 4793‐38‐8
Product: FUSIDIC ACID IMPURITIES
Fusidic Acid EP Impurity A (Sodium Fusidate EP Impurity A/ 24,25‐Dihydroxy Fusidic Acid) 80445‐74‐5
Fusidic Acid EP Impurity B (24,25‐Dihydro‐24,25‐Dihydroxy Fusidic Acid‐21,25‐Lactone)
Fusidic Acid EP Impurity C ((24R)‐24,25‐dihydro‐24,25‐Dihydroxy Fusidic Acid 21,24‐Lactone)
Fusidic Acid EP Impurity D ((24S)‐24,25‐Dihydro‐24,25‐Dihydroxy Fusidic Acid 21,24‐Lactone)
Fusidic Acid EP Impurity G (Sodium Fusidate EP Impurity G/ 3‐Didehydro Fusidic Acid/ 3‐Keto Fusidic Acid) 4680‐37‐9
20.
Fusidic Acid EP Impurity H (Sodium Fusidate EP Impurity H/ 11‐Didehydro Fusidic Acid/ 11‐Keto Fusidic Acid) 16711‐91‐4
Fusidic Acid EP Impurity I (Sodium Fusidate EP Impurity I/ 16‐epi‐Deacetyl Fusidic Acid) 5951‐83‐7
Fusidic Acid EP Impurity L (Sodium Fusidate EP Impurity L/ 9,11‐Anhydro Fusidic Acid) 74048‐41‐2
Fusidic Acid EP Impurity O (16‐Deacetyl Fusidic Acid)
13090‐91‐0
55601‐53‐1
Diethanolamine Fusidate 16391‐75‐6
Product: GABAPENTIN IMPURITIES
Gabapentin EP Impurity A/ Gabapentin Related Compound A (Gabapentin Lactam) 64744‐50‐9
Gabapentin EP Impurity B/ Gabapentin Related Compound B 133481‐09‐1
Gabapentin EP Impurity D/ Gabapentin Related Compound D 1076198‐17‐8
Gabapentin EP Impurity E/ Gabapentin Related Compound E (Gabapentin Diacid)
67950‐95‐2
667465‐00‐1
Gabapentin EP Impurity G 1500558‐49‐5
Gabapentin Impurity 1 (α,α’‐Dicyano‐1,1‐cyclohexanediacetamide) 4355‐15‐1
Gabapentin ‐ In house impurity 872696‐79‐2
Gabapentin Diacetic Acid Impurity (1,1‐Cyclohexane diacetic acid) 4355‐11‐7
1,1‐cyclohexane diacetic monoamide 887589‐52‐8
1,1‐Cyclohexanediacetic Anhydride 1010‐26‐0
Gabapentin ‐ In house impurity/ 1,1‐Cyclohexanediacetic Acid Monoamide 99189‐60‐3
Gabapentin desmethylated beta amino acid impurity
1‐[[(2‐Methyl‐1‐oxopropyl)amino]methyl]cyclohexaneacetic Acid 1281568‐83‐9
Gabapentin Di‐Nitrile Impurity 4172‐99‐0
Product: GALANTAMINE IMPURITIES
Galantamine EP Impurity B (Epi‐Galantamine) 1668‐85‐5
Galantamine EP Impurity C (Dihydro Galantamine/ Lycoramine) 21133‐52‐8
Galantamine EP Impurity D (Anhydro Galantamine) 664995‐65‐7
Galantamine EP Impurity E (N‐Desmethyl Galantamine) 41303‐74‐6
Galantamine EP Impurity F (Ent‐Galantamine) 60384‐53‐4
Galantamine O‐Desmethyl Impurity 60755‐80‐8
Galantamine N‐Oxide Impurity 134332‐50‐6
21.
Product: GANCICLOVIR IMPURITIES
Ganciclovir Divalinate Impurity 130914‐71‐5
Product: GATIFLOXACIN IMPURITIES
Gatifloxacin Related Compound A (8‐Hydroxy Gatifloxacin/ O‐Desmethyl Gatifloxacin) 616205‐76‐6
Gatifloxacin Related Compound B/Moxifloxacin Difluoro Hydroxy Acid Impurity 154093‐72‐8
Gatifloxacin Related Compound C (Moxifloxacin Difluoro Methoxy Acid Impurity/ Ciprofloxacin Difluoro 8‐Methoxy
Impurity) 112811‐72‐0
Gatifloxacin Related Compound D (3‐Desmethyl Gatifloxacin) 112811‐57‐1
Gatifloxacin Related Compound E (Iso‐Gatifloxacin/ Gatifloxacin 2‐Methyl Isomer) 1029364‐65‐5
Gatifloxacin N‐Methyl Impurity 114213‐69‐3
Gatifloxacin Despropylene Impurity 172426‐86‐7
Gatifloxacin Desethylene Impurity 172426‐87‐8
Product: GEFITINIB IMPURITIES
4‐(3‐chloropropyl)morpholine 7357‐67‐7
3‐Hydroxy‐4‐methoxybenzonitrile 52805‐46‐6
Gefitinib O‐Desmethyl Impurity 847949‐49‐9
2‐amino‐4‐methoxy‐5‐(3‐morpholinopropoxy)benzonitrile 675126‐27‐9
4‐methoxy‐5‐(3‐morpholinopropoxy)‐2‐nitrobenzonitrile 675126‐26‐8
4‐methoxy‐3‐(3‐morpholinopropoxy)benzonitrile 675126‐28‐0
3‐hydroxy‐4‐methoxybenzonitrile 52805‐46‐6
Gefitinib O‐Desmorpholinopropyl Impurity 184475‐71‐6
Product: GEMCITABINE IMPURITIES
Gemcitabine EP Impurity A (Lamivudine EP Impurity E/ Cytosine) 71‐30‐7
Gemcitabine EP Impurity B (Gemcitabine alpha‐Isomer/ Gemcitabine 1‐Epimer)
95058‐85‐8
122111‐05‐1
3'‐Epi Gemcitabine 3',5'‐Dibenzoate 1268237‐46‐2
5‐O‐Acetyl Gemcitabine
Gemcitabine 3‐Epimer 103882‐85‐5
Product: GLIBENCLAMIDE/ GLYBURIDE IMPURITIES
Glibenclamide EP Impurity A/ Glyburide Related Compound A 16673‐34‐0
22.
Glibenclamide EP Impurity B/ Glyburide Related Compound B 21165‐77‐5
Glibenclamide EP Impurity C 10079‐35‐3
Glibenclamide EP Impurity D 38160‐73‐5
Glibenclamide EP Impurity E 57334‐89‐1
5‐Chloro‐2‐methoxybenzoic Acid 3438‐16‐2
5‐Chloro‐2‐methoxy‐N‐(2‐phenylethyl)benzamide 33924‐49‐1
Product: GLICLAZIDE IMPURITIES
Gliclazide EP Impurity A (Tolbutamide EP Impurity A/ Toluenesulfonamide) 70‐55‐3
Gliclazide EP Impurity C 5577‐13‐9
Gliclazide EP Impurity F (Gliclazide ortho‐Analog) 1076198‐18‐9
Product: GLIMEPIRIDE IMPURITIES
Glimepiride EP Impurity A/ Glimepiride Related Compound A (Glimepiride cis Isomer) 684286‐46‐2
Glimepiride EP Impurity B/ Glimepiride Related Compound B (Glimepiride Sulfonamide) 119018‐29‐0
Glimepiride EP Impurity C/Glimepiride Related Compound C (Glimepiride Ester) 119018‐30‐3
Glimepiride EP Impurity D/ Glimepiride Related Compound D (Glimepiride meta Isomer) 791104‐62‐6
Glimepiride EP Impurity E/ Glimepiride Related Compound E (Glimepiride meta Sulfonamide)
Glimepiride EP Impurity F/ Glimepiride Related Compound F (Glimepiride ortho Ester)
Glimepiride EP Impurity G/ Glimepiride Related Compound G (Glimepiride N‐Methyl Ester)
Glimepiride EP Impurity H/ Glimepiride Related Compound H (Glimepiride Toluene Analog)
Glimepiride EP Impurity I/ Glimepiride Related Compound I (Glimepiride ortho Isomer) 878480‐70‐7
Glimepiride EP Impurity J/ Glimepiride Related Compound J (Glimepiride ortho Isomer) 41176‐98‐1
4‐(2‐Aminoethyl)benzenesulfonamide
35303‐76‐5
6325‐22‐0
Glimepiride Phenylethyl Impurity 247098‐18‐6
Product: GLIPIZIDE IMPURITIES
Glipizide EP Impurity A 33288‐71‐0
Glipizide EP Impurity B (Cyclohexylamine)
108‐91‐8
4998‐76‐9
26227‐54‐3
Glipizide EP Impurity C 13554‐93‐3
23.
Glipizide EP Impurity D 1346600‐54‐1
Glipizide EP Impurity E (5‐Desmethyl‐6‐Methyl Glipizide/ Glipizide 6‐Methyl Analog) 66375‐96‐0
Glipizide EP Impurity F 192118‐08‐4
Glipizide EP Impurity G 33288‐74‐3
Glipizide EP Impurity H 10080‐05‐4
Glipizide EP Impurity I/ Glibenclamide EP Impurity C 10079‐35‐3
4‐(2‐Aminoethyl)benzenesulfonamide
35303‐76‐5
6325‐22‐0
5‐Methyl‐pyrazine‐2‐carboxylic Acid 5521‐55‐1
Product: GLYCEROL IMPURITIES
Ethylene Glycol 107‐21‐1
Product: GLYCOPYRROLATE IMPURITIES
Glycopyrrolate EP Impurity D (Tiaprofenic Acid EP Impurity D/ Metronidazole Benzoate EP Impurity C/ Mefenamic Acid
EP Impurity D) 65‐85‐0
Product: GRISEOFULVIN IMPURITIES
Griseofulvin Dehydro Impurity 3573‐90‐8
Griseofulvic Acid 469‐54‐5
Product: GUAIFENESIN IMPURITIES
Guaifenesin EP Impurity A (Guaiacol/ 2‐Methoxyphenol) 90‐05‐1
Guaifenesin EP Impurity B 14007‐09‐1
Guaifenesin EP Impurity D 16929‐60‐5
Guaifenesin EP Impurity C 1797132‐23‐0
rac Guaifenesin Cyclic Carbonate (Methocarbamol Dioxolone) 2049‐21‐0
Product: HALOPERIDOL IMPURITIES
Haloperidol EP Impurity F 1391052‐67‐7
Haloperidol EP Impurity H (Haloperidol N‐Oxide) 148406‐51‐3
Trans‐Haloperidol N‐Oxide 150214‐93‐0
Haloperidol Decanoate EP Impurity G 52‐86‐8
Product: HYDRALAZINE IMPURITIES
Hydralazine Hydroxy Impurity 119‐39‐1
25.
Hydrocortisone Acetate EP Impurity G 81968‐66‐3
Product: HYDROXYCHLOROQUINE IMPURITIES
Hydroxychloroquine EP Impurity B (Hydroxychloroquine O‐Sulfate) 103152‐84‐7
Hydroxychloroquine EP Impurity C (Cletoquine) 4298‐15‐1
Hydroxychloroquine EP Impurity D (Desethyl Chloroquine) 1476‐52‐4
Hydroxychloroquine EP Impurity G (Amodiaquine Dichloro Impurity) 86‐98‐6
O‐Acetylhydroxychloroquine 47493‐14‐1
Product: HYMECROMONE IMPURITIES
Hymecromone EP Impurity B 6320‐42‐9
2,4‐Dihydroxyacetophenone 89‐84‐9
Product: HYOSCINE IMPURITIES
Hyoscine EP Impurity C/ Hyoscyamine EP Impurity A (Ipratropium EP Impurity C/ Ipratropium Bromide Related
Compound C/ DL‐Tropic Acid/ Tropicamide EP Impurity C/ Tropicamide Related Compound C/ Hyoscine Butylbromide
EP Impurity B) 552‐63‐6
Product: HYOSCYAMINE IMPURITIES
Hyoscyamine EP Impurity A (Ipratropium EP Impurity C/ Ipratropium Bromide Related Compound C/ DL‐Tropic Acid/
Hyoscine EP Impurity C/ Tropicamide EP Impurity C/ Tropicamide Related Compound C/ Hyoscine Butylbromide EP
Impurity B) 552‐63‐6
Product: HYROXYZINE IMPURITIES
Hydroxyzine EP Impurity A/ Hydroxyzine Related Compound A (Cetirizine EP Impurity A/ Cetirizine Related Compound
A/ Cetirizine CBHP Impurity) 303-26-4
Hydroxyzine EP Impurity B
3733‐63‐9
13073‐96‐6
Hydroxyzine Impurity 2 (Cetirizine EP Impurity D/ Cetirizine Dimer Impurity)
346451‐15‐8
856841‐95‐7
Hydroxyzine Acetic Acid (Cetirizine EP Impurity E)
682323‐77‐9
83881‐56‐5
Product: IBRUTINIB IMPURITIES
4‐phenoxybenzohydrazide 143667‐36‐1
Product: IBUPROFEN IMPURITIES
Ibuprofen EP Impurity A (m‐Isobutyl Ibuprofen) 66622‐47‐7
26.
Ibuprofen EP Impurity B 3585‐49‐7
Ibuprofen EP Impurity C 59512‐17‐3
Ibuprofen EP Impurity D 938‐94‐3
Ibuprofen EP Impurity E/ Ibuprofen Related Compound C 38861‐78‐8
Ibuprofen EP Impurity F 65322‐85‐2
Ibuprofen EP Impurity J/ Ibuprofen Related Compound J (1‐Oxo Ibuprofen) 65813‐55‐0
Ibuprofen EP Impurity L 53949‐53‐4
Ibuprofen EP Impurity N (p‐Ethylhydratropic Acid) 3585‐52‐2
Ibuprofen EP Impurity P (Ibuprofen Alcohol) 36039‐36‐8
2‐(4‐(2‐Methylprop‐1‐enyl)phenyl)propanoic acid 75625‐99‐9
(+) Ibuprofen
(‐) Ibuprofen
Ibuprofen Propyl Analogue 3585‐47‐5
Product: IFOSFAMIDE IMPURITIES
Ifosfamide EP Impurity C 870‐24‐6
Product: ILOPERIDONE IMPURITIES
(S)‐Hydroxy Iloperidone 501373‐88‐2
(R)‐Hydroxy Iloperidone 501373‐87‐1
Iloperidone Dimer Impurity 1375651‐23‐2
Iloperidone Desfluoro Impurity 133454‐46‐3
Iloperidone Hydroxypropoxy Impurity 207298‐39‐3
Acetyl guaiacol 204781‐71‐5
2'‐Hydroxy‐3'‐methoxyacetophenone 703‐98‐0
3‐(4‐Piperidinyl)‐1,2‐benzisoxazole Hydrochloride 84163‐22‐4
1,1'‐((propane‐1,3‐diylbis(oxy))bis(3‐methoxy‐4,1‐phenylene))bis(ethan‐1‐one) 19417‐90‐4
4′‐Hydroxy‐3′‐methoxyacetophenone 498‐02‐2
Product: IMATINIB IMPURITIES
Imatinib EP Impurity A (Imatinib Dimethylamino Impurity) 55314‐16‐4
Imatinib EP Impurity B (Imatinib Guanidino Impurity)
581076‐65‐5
581076‐67‐7
27.
Imatinib EP Impurity C (Imatinib N‐Desmethyl Impurity) 404844‐02‐6
Imatinib EP Impurity D (Imatinib Dimer) 1821122‐73‐9
Imatinib EP Impurity F (Imatinib Diamine Impurity) 152460‐10‐1
Imatinib EP Impurity G (Cyclizine impurity A/ Cyclizine Related Compound A/ 1‐Methylpiperazine)
109‐01‐3
34352‐59‐5
Imatinib EP Impurity H 350‐03‐8
Imatinib EP Impurity I (Metformin EP Impurity F/ Dacarbazine EP Impurity D) 506‐59‐2
Imatinib EP Impurity J (Imatinib Piperazine‐N1‐Oxide) 571186‐91‐9
Imatinib Impurity B 404844‐11‐7
Imatinib Bis Impurity 1365802‐18‐1
Imatinib Carboxylic Impurity 106261‐49‐8
N‐Desmethyl Imatinib
404844‐02‐3
404844‐03‐7
4‐(1‐piperazinylmethyl)benzoic Acid
220213‐15‐0
86620‐70‐4
Ethyl Methane Sulfonate 62‐50‐0
Methyl Methane Sulfonate 66‐27‐3
Methanesulfonic Acid Hexyl Ester 16156‐50‐6
Isopropyl Methane Sulfonate 926‐06‐7
Product: IMIPRAMINE IMPURITIES
Imipramine EP Impurity A (Desipramine HCl)
58‐28‐6
50‐47‐5
5H‐Dibenz[b,f]azepine‐5‐propanamine 303‐54‐8
Product: INDAPAMIDE IMPURITIES
Indapamide EP Impurity C 102789‐79‐7
Triethylamine sulfate 54272‐29‐6
4‐chloro‐3‐sulfamoylbenzoic acid 1205‐30‐7
Product: INDOMETHACIN IMPURITIES
Indomethacin EP Impurity A/ Indomethacin Related Compound B (Acemetacin EP Impurity A/ Bezafibrate EP Impurity B) 74‐11‐3
Indomethacin EP Impurity B/ Indomethacin Related Compound A (Indomethacin N‐Deschlorobenzoyl Impurity) 2882‐15‐7
28.
Indomethacin EP Impurity C 4018‐82‐0
Indomethacin EP Impurity F 402849‐27‐8
Indomethacin EP Impurity J 402849‐25‐6
Product: INTEDANIB IMPURITIES
4‐Chloro‐3‐nitrobenzoic acid 96‐99‐1
Product: IPRATROPIUM BROMIDE IMPURITIES
Ipratropium EP Impurity C/ Ipratropium Bromide Related Compound C (DL‐Tropic Acid/ Hyoscine EP Impurity C/
Hyoscyamine EP Impurity A/ Tropicamide EP Impurity C/ Tropicamide Related Compound C/ Hyoscine Butylbromide EP
Impurity B) 552‐63‐6
Ipratropium Bromide EP Impurity F 17812‐46‐3
Product: IRBESARTAN IMPURITIES
Irbesartan EP Impurity A/ Irbesartan Related Compound A 748812‐53‐5
Irbesartan EP Impurity E (Irbesartan Methyl Impurity/ Losartan EP Impurity E/ Candesartan Methyl Impurity/ Losartan
Methyl Impurity) 120568‐11‐8
Irbesartan Lactam Impurity 151257‐01‐1
Irbesartan Bromo Nitrile Impurity 114772‐54‐2
Irbesartan Cyano Impurity 138401‐24‐8
Irbesartan Dibromomethyl Impurity (Losartan Dibromomethyl Impurity/ Valsartan Dibromomethyl Impurity) 209911‐63‐7
Irbesartan Triphenylmethanol Impurity (Losartan EP Impurity G/ Triphenylmethanol/ Trityl Alcohol/ Candesartan Trityl
Alcohol Impurity/ Zidovudine EP Impurity D) 76‐84‐6
Irbesartan Dibromomethyl Impurity (2’‐Cyano‐4‐(dibromomethyl)biphenyl) 209911‐63‐7
Irbesartan Hydroxy Impurity (Candesartan Hydroxy Impurity/ Losartan Hydroxy Impurity/ Losartan EP Impurity B) 160514‐13‐6
Irbesartan Dibromo N2‐Trityl Impurity (Candesartan Dibromo N2‐Trityl Impurity/ Candesartan Dibromo TTBB Impurity/
Losartan Dibromo N2‐Trityl Impurity/ Olmesartan Dibromo N2‐Trityl Impurity/ Valsartan Dibromo N2‐Trityl Impurity) 151052‐34‐5
Irbesartan Dimer Impurity 1346598‐52‐4
Demethyl Irbesartan 158778‐58‐6
2‐[4‐(aminomethyl)phenyl]benzonitrile 133690‐92‐3
Product: IRINOTECAN IMPURITIES
29.
Irinotecan EP Impurity E/ Irinotecan Related Compound B (7‐Ethyl‐10‐Hydroxy Camptothecin/ 11‐Ethyl‐9‐Hydroxy
Camptothecin) 86639‐52‐3
Irinotecan EP Impurity G/ Irinotecan Related Compound G (7,11‐Diethyl‐10‐hydroxycamptothecin/ 8,11‐Diethyl‐9‐
Hydroxy Camptothecin) 947687‐01‐6
Product: ISOCONAZOLE IMPURITIES
Isoconazole EP Impurity B (Tioconazole EP Impurity D/ Fenticonazole EP Impurity A/ Econazole EP Impurity A/
Econazole Related Compound A/ Miconazole EP Impurity A/ Deschlorobenzyl Econazole/ Isoconazole Nitrate EP
Impurity A) 24155‐42‐8
Product: ISOCONAZOLE NITRATE IMPURITIES
Isoconazole Nitrate EP Impurity A (Isoconazole EP Impurity B/ Tioconazole EP Impurity D/ Fenticonazole EP Impurity A/
Econazole EP Impurity A/ Econazole Related Compound A/ Miconazole EP Impurity A/ Deschlorobenzyl Econazole) 24155‐42‐8
Product: ISONIAZID IMPURITIES
Isoniazid dimer (1,2‐Diisonicotinoylhydrazine) 4329‐75‐3
2‐Isoniazid 1452‐63‐7
Product: ITRACONAZOLE IMPURITIES
Itraconazole EP Impurity A (Itraconazole 4‐Methoxy Derivative) 252964‐68‐4
Itraconazole EP Impurity B 854372‐77‐3
Itraconazole EP Impurity C (Propyl Itraconazole) 74855‐91‐7
Itraconazole EP Impurity D (Isopropyl Itraconazole) 89848‐49‐7
Itraconazole EP Impurity E (trans‐Itraconazole) 252964‐65‐1
Itraconazole EP Impurity F (Butyl Itraconazole) 89848‐51‐1
Itraconazole EP Impurity G
1‐(4‐Methyloxy‐phenyl)‐4‐(4‐nitro‐phenyl)‐piperazine 74852‐61‐2
Product: IVABRADINE IMPURITIES
Ivabradine N‐Oxide
N‐Desmethyl Ivabradine 1246638‐08‐3
Ivabradine Dehydro Impurity 1086026‐31‐4
Hydroxy Ivabradine 1235547‐07‐5
7,8‐Dimethoxy‐1,3‐dihydro‐2H‐3‐benzazepin‐2‐one 73942‐87‐7
3‐(3‐Chloropropyl)‐1,3,4,5‐tetrahydro‐7,8‐dimethoxy‐2H‐3‐benzazepin‐2‐one 85175‐65‐1
Ivabradine HCl R‐Isomer 148849‐68‐7
30.
Product: IVACAFTOR IMPURITIES
Ivacaftor Carboxylic Acid Impurity 1246213‐24‐0
Ivacaftor Hydroxymethyl Impurity 1246213‐23‐9
Product: IVERMECTIN IMPURITIES
Ivermectin EP Impurity A (Avermectin B1a) 65195‐55‐3
Ivermectin EP Impurity D 102190‐55‐6
Product: KETOCONAZOLE IMPURITIES
Ketoconazole EP Impurity C (Ketoconazole 4‐Epimer) 83374‐59‐8
Ketoconazole EP Impurity E 134071‐44‐6
1‐Acetyl‐4‐(4‐hydroxyphenyl)piperazine 67914‐60‐7
Product: KETOPROFEN IMPURITIES
Ketoprofen EP Impurity A/ Ketoprofen Related Compund D 66067‐44‐5
Ketoprofen EP Impurity B (Desmethyl Ketoprofen) 22071‐22‐3
Ketoprofen EP Impurity C/ Ketoprofen Related Compund C 68432‐95‐1
Ketoprofen EP Impurity D/ Ketoprofen Related Compund A 107257‐20‐5
Ketoprofen EP Impurity E (Ketoprofen Amide) 59512‐16‐2
Ketoprofen EP Impurity F/ Ketoprofen Related Compund F 42872‐30‐0
Ketoprofen EP Impurity G 5537‐71‐3
N‐Boc‐glycine 4530‐20‐5
Product: KETOROLAC IMPURITIES
Ketorolac EP Impurity A/ Ketorolac Related Compound B (1‐Hydroxy Ketorolac) 154476‐25‐2
Ketorolac EP Impurity B/ Ketorolac Related Compound C (1‐Keto Ketorolac) 113502‐52‐6
Ketorolac EP Impurity C (6‐Benzoyl Ketorolac) 1026936‐07‐1
Ketorolac EP Impurity D (1‐Methoxy Ketorolac) 1391053‐45‐4
Ketorolac EP Impurity E/ Ketorolac Related Compound A (Ketorolac Tris Amide) 167105‐80‐8
Ketorolac EP Impurity G (1‐Hydroxy Ketorolac Methyl Ester) 1391051‐90‐3
Ketorolac EP Impurity H (Ketorolac Methyl Ester) 80965‐09‐9
Ketorolac EP Impurity I/ Ketorolac Related Compound D (1‐Decarboxy Ketorolac) 113502‐55‐9
Ketorolac EP Impurity J (Ketorolac Ethyl Ester) 108061‐03‐6
Ketorolac Trometamol/ Ketorolac Tromethamine 74103‐07‐4
31.
Ketorolac 4‐Hydroxy Metabolite 111930‐01‐9
Ketorolac Bromo Impurity 328936‐18‐1
Ketorolac Acid 74103‐06‐3
Product: KETOTIFEN IMPURITIES
Ketotifen EP Impurity A 4673‐38‐5
Ketotifen EP Impurity G (9,10‐Dioxo Ketotifen) 43076‐16‐0
Product: LABETALOL IMPURITIES
Labetalol EP Impurity A (Labetalol 1‐Carboxylic Acid) 1391051‐99‐2
Labetalol EP Impurity B (Labetalol 1‐Carboxylic Acid Methyl Ester)
802620‐01‐5
33778‐93‐7
Labetalol EP Impurity C
Labetalol EP Impurity D 32780‐65‐7
Labetalol EP Impurity E (Labetalol Piperadine Dimer)
Labetalol EP Impurity F
127988‐63‐0
96441‐14‐4
Labetalol EP Impurity G
5‐(2‐(diphenethylamino)acetyl)‐2‐hydroxybenzamide 30566‐92‐8
Labetalol Acetonide Impurity
5‐Acetyl‐2‐(phenylmethoxy)benzamide 75637‐30‐8
3‐Amino‐1‐(4‐hydroxyphenyl)butane 52846‐75‐0
Product: LACIDIPINE IMPURITIES
Lacidipine EP Impurity A (Lacidipine Ethyl Methyl Diester) 103890‐81‐9
Lacidipine EP Impurity B (Dehydro Lacidipine) 130996‐24‐6
2‐Formylbenzoic Acid 119‐67‐5
2‐Vinyl benzaldehyde 28272‐96‐0
Product: LACOSAMIDE IMPURITIES
Lacosamide EP Impurity A (Lacosamide (S)‐Isomer) 175481‐37‐5
Lacosamide EP Impurity B (Lacosamide O‐Acetyl Impurity) 1318777‐54‐6
Lacosamide EP Impurity D (Lacosamide N‐Desacetyl Impurity) 196601‐69‐1
Lacosamide EP Impurity E (Lacosamide N‐Desacetyl O‐Desmethyl Impurity) 175481‐39‐7
32.
Lacosamide EP Impurity F (Lacosamide O‐Desmethyl Impurity) 175481‐38‐6
Lacosamide EP Impurity G (N‐Benzylacetamide) 588‐46‐5
Lacosamide EP Impurity I ((S)‐N‐benzyl‐2‐(3‐benzylureido)‐3‐methoxypropanamide)
Lacosamide EP Impurity J (Phenylmethanamine) 100‐46‐9
Lacosamide Impurity K 86921‐49‐5
Lacosamide Related Compound F 171623‐02‐2
N‐Methyl Lacosamide 388619‐64‐5
N‐acetyl O‐methyl L‐serine methyl ester
1,3‐Dibenzyl‐urea 1466‐67‐7
(R)‐2‐(Acetylamino)‐3‐methoxypropionic Acid 196601‐67‐9
Lacosamide N‐Ethylcarbonyl Analog 1318777‐56‐8
Product: LAMIVUDINE IMPURITIES
Lamivudine EP Impurity A (Lamivudine Acid) 173829‐09‐9
Lamivudine EP Impurity C (Acetylsalicylic Acid EP Impurity C/ Salicylic Acid/ Mesalazine EP Impurity H/ Sulfasalazine EP
Impurity H) 69‐72‐7
Lamivudine EP Impurity D (ent‐Lamivudine) 134680‐32‐3
Lamivudine EP Impurity E (Cytosine/ Gemcitabine EP Impurity A) 71‐30‐7
Lamivudine EP Impurity F (Fluorouracil EP Impurity C/ Uracil) 66‐22‐8
Lamivudine EP Impurity G (Lamivudine (3S)‐Sulfoxide) 160552‐55‐6
Lamivudine EP Impurity H (Lamivudine (3R)‐Sulfoxide) 160552‐54‐5
Lamivudine EP Impurity J (Lamivudine Dione Impurity) 145986‐07‐8
Lamivudine 5‐Epimer 139757‐68‐9
Lamivudine 2‐Epimer 136846‐20‐3
Product: LAMOTRIGINE IMPURITIES
Lamotrigine EP Impurity A/ Lamotrigine Related Compound C 252186‐78‐0
Lamotrigine EP Impurity B & Lamotrigine EP Impurity C Mixture
94213‐24‐8
94213‐23‐7
84689‐20‐3
Lamotrigine EP Impurity D 661463‐79‐2
33.
Lamotrigine EP Impurity E/ Lamotrigine Related Compound B 50‐45‐3
Lamotrigine EP Impurity F/ Lamotrigine Related Compound D 252186‐79‐1
Lamotrigine EP Impurity G 38943‐76‐9
2,3‐dichloro benzoyl cyanide 77668‐42‐9
2,3‐Dichloro benzoyl chloride 2905‐60‐4
Hydroxyamino Lamotrigine/ Lamotrigine Hydroxyl Amine
Lamotrigine N2‐Oxide 136565‐76‐9
Lamotrigine 3,3 Dimer Impurity 1797983‐48‐2
2,3‐Dichlorobenzoic Acid Anhydride 252186‐80‐4
2,4‐Dichlorobenzoyl Chloride 89‐75‐8
2,5‐Dichlorobenzoyl Chloride 2905‐61‐5
3,4‐Dichlorobenzoyl Chloride 3024‐72‐4
2,3‐Dichlorobenzoic Anhydride 51417‐52‐8
2,4 Dichlorobenzoyl Nitrile 35022‐43‐6
2,5 Dichlorobenzoyl nitrile 64985‐85‐9
Product: LANSOPRAZOLE IMPURITIES
Lansoprazole EP Impurity A (Lansoprazole N‐Oxide) 213476‐12‐1
Lansoprazole EP Impurity B/ Lansoprazole Related Compound A (Lansoprazole Sulfone) 131926‐99‐3
Lansoprazole EP Impurity C/ Lansoprazole Related Compound B (Lansoprazole Sulfide) 103577‐40‐8
Lansoprazole EP Impurity D (Rabeprazole EP Impurity K) 615‐16‐7
Lansoprazole EP Impurity E (Rabeprazole Related Compound C) 583‐39‐1
Lansoprazole EP Impurity F (Rabeprazole EP Impurity H/Rabeprazole Related Compound F/ Rabeprazole 4‐Chloro
Analog) 168167‐42‐8
Lansoprazole EP Impurity F Sulfide (4‐Desmethoxypropoxyl‐4‐Chloro Rabeprazole Sulfide/ Lansoprazole Sulfide 4‐Chloro
Analog) 103312‐62‐5
Lansoprazole Sulphone N‐Oxide 953787‐54‐7
Lansoprazole Sulfide N‐Oxide 163119‐30‐0
Lansoprazole S‐Isomer/ Levolansoprazole 138530‐95‐7
Lansoprazole Chloromethyl Impurity 127337‐60‐4
34.
4‐chloro‐2‐(chloromethyl)‐3‐methylpyridine hydrochloride 152402‐97‐6
Lansoprazole 4‐Nitro Analog 142384‐07‐4
Lansoprazole 5‐Hydroxy Impurity
131926‐98‐2
1329613‐29‐7
Lansoprazole Hydroxymethyl Impurity 103577‐66‐8
Lansoprazole Nitro Impurity 37699‐43‐7
Lansoprazole R‐Isomer 138530‐94‐6
Lansoprazole Sulfide 4‐Hydroxy Analog 131926‐97‐1
Lansoprazole Thioxo Impurity 1246819‐06‐6
Product: LANTHNUM CARBONATE IMPURITIES
Lanthanum hydroxyl carbonate Form‐I
Lanthanum hydroxyl carbonate Form‐II
Product: LATANOPROST IMPURITIES
Latanoprost Related Compound A (5,6‐trans‐Latanoprost) 913258‐34‐1
15‐Keto Latanoprost 135646‐98‐9
Latanoprost‐ Acid 41639‐83‐2
15‐epi Latanoprost 145773‐22‐4
5‐(Diphenylphosphoryl)pentanoic acid 71140‐70‐0
Methyl 5‐(diphenylphosphoryl)pentanoate 146964‐27‐4
15‐Keto Latanoprost Acid 369585‐22‐8
Product: LEFLUNOMIDE IMPURITIES
Leflunomide EP Impurity A/ Leflunomide Related Compound A 455‐14‐1
Leflunomide EP Impurity B/ Leflunomide Related Compound B 163451‐81‐8
Leflunomide EP Impurity C (Leflunomide‐3‐isomer) 61643‐23‐0
Leflunomide EP Impurity D (5‐Methylisoxazole‐4‐carboxylic Acid) 42831‐50‐5
Leflunomide EP Impurity E (5‐Desmethyl‐3‐methyl Leflunomide) 208401‐20‐1
Leflunomide EP Impurity F (Leflunomide‐2‐isomer) 1403564‐06‐6
Leflunomide EP Impurity G (5‐methyl‐N‐(p‐tolyl)isoxazole‐4‐carboxamide) 724429‐16‐7
Leflunomide EP Impurity H (2‐Cyano‐N‐[4‐(trifluoromethyl)phenyl]acetamide) 24522‐30‐3
Leflunomide Impurity (Ethyl 5‐methylis/ 5‐METHYL‐4‐ISOXAZOLECARBOXYLATE) 51135‐73‐0
36.
Product: LETROZOLE IMPURITIES
Letrozole EP Impurity A/ Letrozole Related Compound A (Iso Letrozole) 112809‐52‐6
Letrozole EP Impurity B 113402‐31‐6
Letrozole 4‐Descyano 4‐Bromo Impurity 143030‐54‐0
4,4'‐Methylenedibenzonitrile 10466‐37‐2
Product: LEVALBUTEROL IMPURITIES
Levalbuterol Related Compound B (Salbutamol EP Impurity C/ 2‐Deshydroxy Salbutamol/ Albuterol Related Compound
A) 18910‐68‐4
Levalbuterol Related Compound D (Salbutamol EP Impurity D/ Salbutamol Aldehyde Impurity) 156339‐88‐7
Levalbuterol Related Compound E 69716‐64‐9
Levalbuterol Related Compound H (Salbutamol EP Impurity A/ Salbutamol Methyl Ether) 870076‐72‐5
Product: LEVAMISOLE IMPURITIES
Levamisole EP Impurity D 4335‐28‐8
Product: LEVETIRACETAM IMPURITIES
Levetiracetam EP Impurity A (Levetiracetam Carboxylic Acid Racemate) 67118‐31‐4
Levetiracetam EP Impurity B 358629‐47‐7
Levetiracetam EP Impurity C
72762‐00‐6
142‐08‐5
Levetiracetam EP Impurity D (Levetiracetam R‐Isomer) 103765‐01‐1
Levetiracetam EP Impurity E/ (R)‐(+)‐Phenyl ethyl amine 3886‐69‐9
Levitiracetam Related compound A 102767‐31‐7
Levitiracetam Related compound B 7682‐20‐4
Levetiracetam Impurity 3 (Piracetam EP Impurity A/ Povidone EP Impurity B/ pyrrolidin‐2‐one/2‐Oxo‐4‐butyrolactam) 616‐45‐5
Levetiracetam Racemate (Etiracetam) 33996‐58‐6
Levetiracetam Acid 103833‐72‐3
Levetiracetam Carboxylic Acid 102849‐49‐0
(S)‐(‐)‐1‐Phenylethylamine 2627‐86‐3
Product: LEVOCETRIZINE IMPURITIES
4‐Chlorobenzhydryl Chloride 134‐83‐8
37.
Levocetirizine Amide 909779‐33‐5
Levocetirizine Ethyl Ester 1116338‐10‐3
Product: LEVODOPA IMPURITIES
Levodopa EP Impurity A/ Levodopa Related Compound A (2‐Hydroxy Levodopa) 27244‐64‐0
Levodopa EP Impurity B (L‐Tyrosine) 60‐18‐4
Levodopa EP Impurity C/ Levodopa Related Compound B (3‐Methyl‐DL‐Dopa/ 3‐Methoxy‐DL‐tyrosine) 7636‐26‐2
Levodopa EP Impurity D (D‐Dopa) 5796‐17‐8
L‐Veratrylglycine (DMPA) 32161‐30‐1
Product: LEVODROPROPIZINE IMPURITIES
Levodropropizine EP Impurity A (Dextrodropropizine/ Dropropizine R‐Isomer) 99291‐24‐4
Levodropropizine EP Impurity B 92‐54‐6
Levodropropizine EP Impurity C (Glycidol) 556‐52‐5
Product: LEVOFLOXACIN IMPURITIES
Levofloxacin EP Impurity B/ Levofloxacin Related Compound A (N‐Desmethyl Levofloxacin) 117707‐40‐1
Levofloxacin EP Impurity C (Levofloxacin N‐oxide/ Oxifloxacin EP Impurity F)
117678‐38‐3
117678‐37‐2
Levofloxacin EP Impurity D/ Levofloxacin Related Compound F (Levofloxacin Desfluoro Impurity) 117620‐85‐6
Levofloxacin EP Impurity E (Levofloxacin Descarboxy Impurity) 178964‐53‐9
Levofloxacin EP Impurity F/ Levofloxacin Related Compound B (Levofloxacin Difluoro Carboxylic Acid) 100986‐89‐8
Levofloxacin EP Impurity G/ Levofloxacin Related Compound E (Levofloxacin Desethylene Impurity) 1346603‐62‐0
Levofloxacin EP Impurity H/ Levofloxacin Related Compound C (Levofloxacin Ethyl Ester) 177472‐30‐9
Levofloxacin EP Impurity I (Levofloxacin 9‐Piperazinyl Isomer) 178912‐62‐4
Ofloxacin ‐ Racemic mixture 82419‐36‐1
Ofloxacin R‐Isomer 100986‐86‐5
Desmethyl Ofloxacin (Ofloxacin EP Impurity E) 82419‐52‐1
Levofloxacin Diamine Impurity (N,N‐Didesethylene Levofloxacin)
1797510‐34‐9
1797099‐76‐3
2,3,4‐Trifluoro‐α‐[[[(1S)‐2‐hydroxy‐1‐methylethyl]amino]methylene]‐β‐oxo‐benzenepropanoic Acid Ethyl Ester 601490‐35‐1
N,N’‐Desethylene Levofloxacin Hydrochloride 151250‐76‐9
38.
Product: LEVONORGESTREL IMPURITIES
Tetralone 1078‐19‐9
Product: LEVOSULPIRIDE IMPURITIES
(2S)‐2‐Aminomethyl‐1‐ethylpyrrolidine 22795‐99‐9
Product: LEVOTHYROXINE IMPURITIES
Levothyroxine EP Impurity B 1628720‐66‐0
Levothyroxine EP Impurity C/ Levothyroxine T3‐Acetic Acid (Liothyronine EP Impurity C/ Triiodothyroacetic Acid) 51‐24‐1
Levothyroxine EP Impurity D/ T4‐Acetic Acid (Liothyronine EP Impurity D/ Tetraiodothyroacetic Acid) 67‐30‐1
Levothyroxine EP Impurity E (Liothyronine EP Impurity E/ Diiodothyronine/ 3,5‐Diiodo‐L‐thyronine) 1041‐01‐6
Levothyroxine EP Impurity F (Levothyroxine T6 Impurity) 911661‐90‐0
Levothyroxine EP Impurity H (Levothyroxine Benzoic Acid Impurity) 2055‐97‐2
Levothyroxine EP Impurity I 2016‐06‐0
Levothyroxine EP Impurity J 4604‐41‐5
Levothyroxine EP Impurity K 5817‐39‐0
Levothyroxine T4‐Acetamide Impurity 176258‐88‐1
Levothyroxine beta‐Hydroxy Impurity 107849‐54‐7
Levothyroxine D‐Isomer 51‐49‐0
Levothyroxine Ethyl Ester 76353‐71‐4
Levothyroxine Hydroxyphenoxy Aldehyde Impurity (3,5‐Diiodo Thyroaldehyde) 828‐49‐1
Levothyroxine Methyl Ester 32180‐11‐3
Levothyroxine N‐Acetyl Impurity 26041‐51‐0
Levothyroxine N‐Formyl Impurity 671235‐41‐9
Levothyroxine T4‐Hydroxyacetic Acid 93647‐48‐4
L‐Thyronine/ Desiodothyroxine 1596‐67‐4
Levothyroxine In house Impurity 5563‐89‐3
Product: LICARBAZEPINE IMPURITIES
Licarbazepine R‐Isomer 104746‐03‐4
Licarbazepine Acetate R‐Isomer 186694‐45‐1
Product: LIDOCAINE IMPURITIES
40.
Linagliptin 8‐Bromo Impurity 93703‐24‐3
Linagliptin 3‐Methyl Xanthine Impurity (Pentoxifylline EP Impurity B/ Theophylline EP Impurity B) 1076‐22‐8
Linagliptin Glucose adduct
Linagliptin‐HBr adduct
Linagliptin Dimer
Des‐Bromolinagliptin
7‐benzyl‐8‐bromo‐3‐methyl‐1H‐purine‐2,6(3H,7H)‐dione 93703‐26‐5
8‐Bromo‐7‐(but‐2‐yn‐1‐yl)‐3‐methyl‐1Hpurin‐2,6(3H,7H)‐dione 666816‐98‐4
7‐(but‐2‐yn‐1‐yl)‐3‐methyl‐1H‐purine‐2,6(3H,7H)‐dione 586408‐08‐4
(4‐methylquinazolin‐2‐yl)methanol 13535‐91‐6
7‐benzyl‐3‐methyl‐1H‐purine‐2,6(3H,7H)‐dione 56025‐86‐6
7‐(but‐2‐yn‐1‐yl)‐8‐(dimethylamino)‐3‐methyl‐1‐((4‐methylquinazolin‐2‐yl)methyl)‐1H‐purine‐2,6(3H,7H)‐dione 1646355‐34‐1
Linagliptin Regio‐isomer 1446263‐38‐2
N‐Phthalimidelinagliptin 886588‐63‐2
(R)‐3‐Amino‐1‐benzylpiperidine 168466‐84‐0
Product: LINCOMYCIN IMPURITIES
Lincomycin EP Impurity C (N‐Desmethyl Lincomycin)
2256‐16‐8
14600‐41‐0
Lincomycin EP Impurity B 37744‐65‐3
Product: LINEZOLID IMPURITIES
Linezolid Related Compund A (Linezolid Desacetamide Azide) 168828‐84‐0
Linezolid Related Compund B (ThioLinezolid) 216868‐57‐4
Linezolid Related Compund C (Linezolid Desacetyl Analog) 168828‐90‐8
Linezolid Related Compound D (Linezolid Mesylate Impurity) 174649‐09‐3
Linezolid Benzyl Impurity 168828‐81‐7
Linezolid Amine Impurity 93246‐53‐8
Linezolid Intermediate Impurity‐3 2689‐39‐6
Linezolid Desfluoro Impurity 556801‐15‐1
Linezolid R‐Isomer 872992‐20‐6
41.
Linezolid Dimer 908143‐04‐4
Linezolid N‐Oxide 189038‐36‐6
Linezolid Hydroxymethyl Impurity (Linezolid Desacetamide Hydroxy Impurity) 168828‐82‐8
3‐chloro‐2‐hydroxypropyl butanoate 3478‐20‐4
Linezolid N‐Desacetyl (R)‐Isomer 912359‐80‐9
Linezolid Descarbonyl (S)‐Isomer 1561176‐27‐9
Linezolid Descarbonyl N‐Desacetyl N‐Acetyl Impurity
333753‐69‐8
1391068‐25‐9
Product: LIOTHYRONINE IMPURITIES
Liothyronine EP Impurity A (Levothyroxine)
51‐48‐9
55‐03‐8
25416‐65‐3
Liothyronine EP Impurity B 300‐39‐0
Liothyronine EP Impurity C (Triiodothyroacetic Acid/ Levothyroxine EP Impurity C/ Levothyroxine T3‐Acetic Acid) 51‐24‐1
Liothyronine EP Impurity D (Tetraiodothyroacetic Acid/ Levothyroxine EP Impurity D/ T4‐Acetic Acid) 67‐30‐1
Liothyronine EP Impurity E (Levothyroxine EP Impurity E/ Diiodothyronine/ 3,5‐Diiodo‐L‐thyronine) 1041‐01‐6
Product: LISINOPRIL IMPURITIES
Lisinopril EP Impurity A (Lisinopril CPP Impurity/ Lisinopril APBA Impurity) 1012‐05‐1
Lisinopril EP Impurity B (Tizanidine EP Impurity I, Anastrozole EP Impurity F, Sultamicillin EP Impurity B)
104‐15‐4
6192‐52‐5
Lisinopril EP Impurity C/ Lisinopri Related Compund A (Lisinopril (S,S,S)‐Diketopiperazine) 328385‐86‐0
Lisinopril EP Impurity D (Lisinopril (S,S,R)‐Diketopiperazine) 219677‐82‐4
Lisinopril EP Impurity E/ Lisinopril (1R)‐Epimer (Lisinopril (R,S,S)‐Isomer)
85955‐59‐5
1356019‐70‐9
Lisinopril EP Impurity F (Lisinopril Cyclohexyl Analog) 1132650‐67‐9
Lisinopril EP Impurity G (lisinopril Dimer) 1356839‐89‐8
Lisinopril EP Impurity H (Lisinopril CPP Lysine Impurity/ Lisinopril Des‐Proline Impurity) 138247‐43‐5
Lisinopril EP Impurity I (N‐Alkyl lisinopril) 927819‐64‐5
Product: LOMUSTINE IMPURITIES
Lomustine Related Compound B 13908‐11‐7
42.
Lomustine Related Compound C 2387‐23‐7
cis‐4‐Hydroxy‐lomustine 52049‐26‐0
trans‐4‐Hydroxy‐lomustine 56239‐24‐8
Product: LOPERAMIDE IMPURITIES
Loperamide EP Impurity A 1391052‐94‐0
Loperamide EP Impurity B
Loperamide EP Impurity C 39512‐49‐7
Loperamide EP Impurity D 37743‐41‐2
Loperamide EP Impurity F/ Loperamide Related Compound F (Loperamide N‐Oxide) 106900‐12‐3
Loperamide EP Impurity G 109572‐89‐6
Loperamide EP Impurity H 61299‐42‐1
Dimethyl‐(tetrahydro‐3,3‐diphenyl‐2‐furilidine)ammonium Bromide 37743‐18‐3
Product: LOPINAVIR IMPURITIES
Lopinavir 4‐Oxo Analog/ Lopinavir Metabolite M1 192725‐39‐6
Lopinavir 4‐Hydroxy Analog 357275‐54‐8
4,5‐Dehydro(pyrimidin‐2(1H)‐one) Lopinavir
Product: LORATIDINE IMPURITIES
Loratidine EP Impurity A/ Loratidine Related Compound F 133284‐74‐9
Loratidine EP Impurity B/ Loratidine Related Compound C 31251‐41‐9
Loratadine EP Impurity C/ Loratadine Related Compound G 165739‐83‐3
Loratidine EP Impurity D/ Loratidine Related Compound A (Desloratadine) 100643‐71‐8
Loratadine EP Impurity E 170727‐59‐0
Loratadine EP Impurity F 125743‐80‐8
Loratidine EP Impurity G/ Loratidine Related Compound B (N‐Methyl Desloratadine/ 8‐Chloro Azatadine) 38092‐89‐6
Loratadine EP Impurity H 29976‐53‐2
Loratidine Related Compound D (Desloratadine 11‐Hydroxy N‐Methyl Impurity) 38089‐93‐9
Loratidine Related Compound E (Loratadine Dichloro Impurity) 133330‐60‐6
Loratadine Related Compound I (Dehydro Loratadine) 133330‐56‐0
Loratadine impurity A (Desloratadine Deschloro Impurity/ N‐Desmethyl Azatadine) 38092‐95‐4
43.
Loratadine N‐Formyl Impurity (Desloratadine Related Compound F/ Desloratadine N‐Formyl Impurity) 117810‐61‐4
Desloratadine 8‐Bromo‐N‐Methyl Impurity 130642‐57‐8
Desloratadine Related Compound A (Desloratadine 8‐Bromo Analog) 117796‐50‐6
Loratadine 8‐Bromo Impurity 130642‐60‐3
Loratadine Methanone Impurity (Desloratadine Methanone Impurity/ Desloratadine Ketone Impurity) 119770‐60‐4
Loratadine N‐Oxide 165739‐62‐8
Loratadine Desethoxycarbonyl 3‐Hydroxy Impurity (Desloratadine 3‐Hydroxy Impurity) 119410‐08‐1
Product: LORCASERIN IMPURITIES
(S)‐Lorcaserin
616202‐81‐4
1006037‐59‐7
Product: LOSARTAN IMPURITIES
Losartan EP Impurity A 79047‐41‐9
Losartan EP Impurity B (Losartan Hydroxy Impurity/ Irbesartan Hydroxy Impurity/ Candesartan Hydroxy Impurity) 160514‐13‐6
Losartan EP Impurity C (Losartan 5‐Chloro Isomer/ Isolosartan)
114799‐13‐2
860644‐28‐6
Losartan EP Impurity D/ Losartan Related Compund A 83857‐96‐9
Losartan EP Impurity E (Losartan Methyl Impurity/ Irbesartan EP Impurity E/ Irbesartan Methyl Impurity/ Candesartan
Methyl Impurity) 120568‐11‐8
Losartan EP Impurity F (Losartan Isopropyl Ether) 1332713‐64‐0
Losartan EP Impurity G (Triphenylmethanol/ Trityl Alcohol/ Candesartan Trityl Alcohol Impurity/ Irbesartan
Triphenylmethanol Impurity/ Zidovudine EP Impurity D) 76‐84‐6
Losartan EP Impurity H (N2‐Trityl Losartan) 133909‐99‐6
Losartan EP Impurity I (O‐Trityl Losartan/ Losartan Trityl Ether) 1006062‐28‐7
Losartan EP Impurity J/ Losartan Related Compound B (Losartan Acetate/ O‐Acetyl Losartan) 1006062‐27‐6
Losartan EP Impurity K/ Losartan Related Compound C (Losartan Aldehyde) 114798‐36‐6
Losartan EP Impurity L/ Losartan Related Compound D (Losartan N1‐Dimer ; N1‐Losartanyl Losartan) 230971‐71‐8
Losartan EP Impurity M/ Losartan Related Compound E (Losartan N2‐Dimer/ N2‐Losartanyl Losartan) 230971‐72‐9
45.
exo‐2,3‐Norbornanedicarboximide 14805‐29‐9
3‐[4‐(methylsulfonyl)‐1‐piperazinyl]‐1,2‐Benzisothiazole 2190680‐18‐1
Lurasidone DBI Piperazine Impurity (Ziprasidone EP Impurity P) 223586‐82‐1
((1R,2R)‐cyclohexane‐1,2‐diyl)bis(methylene) dimethanesulfonate 186204‐35‐3
(1R,2R)‐1,2‐cyclohexanedimethanol 65376‐05‐8
3‐Chloro‐1,2‐benzisothiazole 7716‐66‐7
Product: LYMECYCLINE IMPURITIES
Lymecycline EP Impurity G
57‐62‐5
64‐72‐2
Lymecycline EP Impurity H 64‐75‐5
Product: MACITENTAN IMPURITIES
2‐[[6‐Amino‐5‐(4‐bromophenyl)‐4‐pyrimidinyl]oxy]‐ethanol 2211059‐05‐9
6‐Amino‐5‐(4‐bromophenyl)‐4(3H)‐pyrimidinone 2211054‐46‐3
5‐(4‐Bromophenyl)‐4,6‐dichloropyrimidine 146533‐41‐7
5‐Des‐bromo‐macitentan 2211059‐00‐4
Dimethyl (4‐Bromophenyl)malonate 149506‐35‐4
N‐Propylsulfamide Potassium Salt 1393813‐41‐6
Macitentan N‐Despropyl‐N‐Methyl Impurity/ Macitentan N‐methyl Analog 441798‐25‐0
Macitentan N‐Despropyl‐N‐Ethyl Impurity/ Macitentan N‐Ethyl Analog 441796‐13‐0
Product: MANNITOL IMPURITIES
sorbitol 50‐70‐4
Maltitol 585‐88‐6
Product: MEBENDAZOLE IMPURITIES
Mebendazole EP Impurity A/ Mebendazole Related Compound A (Mebendazole Amine Impurity) 52329‐60‐9
Mebendazole EP Impurity B/ Mebendazole Related Compound B (Mebendazole 2‐Hydroxy) 21472‐33‐3
Mebendazole EP Impurity C/ Mebendazole Related Compound C 66066‐76‐0
Mebendazole EP Impurity D/ Mebendazole Related Compound D (Mebendazole 1‐Methyl) 132119‐11‐0
Product: MEBEVERINE IMPURITIES
Mebeverine EP Impurity D 93‐07‐2
46.
Product: MECLIZINE IMPURITIES
Meclizine Related Compound A (Cetirizine 4‐Chlorobenzhydrol Impurity) 119‐56‐2
Product: MEDETOMIDINE IMPURITIES
Medetomidine Hydroxy Impurity 86347‐12‐8
Medetomidine Hydroxy N‐Benzyl Impurity 2250243‐44‐6
Medetomidine N‐Benzyl Impurity 2250242‐52‐3
Medetomidine Ethyl Impurity
Product: MEFENAMIC ACID IMPURITIES
Mefenamic Acid EP Impurity A
87‐59‐2
5417‐45‐8
Mefenamic Acid EP Impurity B 21122‐68‐9
Mefenamic Acid EP Impurity C (Mesalazine EP Impurity L) 118‐91‐2
Mefenamic Acid EP Impurity D (Metronidazole Benzoate EP Impurity C/ Tiaprofenic Acid EP Impurity D/ Glycopyrrolate
EP Impurity D) 65‐85‐0
Mefenamic Acid EP Impurity E 4869‐11‐8
Product: MEFLOQUINE IMPURITIES
Mefloquine EP Impurity A 35853‐55‐5
Mefloquine EP Impurity B (Dehydro Mefloquine) 68496‐04‐8
Mefloquine EP Impurity C
58737‐31‐8
58560‐52‐4
Product: MELATONIN IMPURITIES
Melatonin Related Compound A (N‐Desacetyl Melatonin/ 5‐Methoxytryptamine) 608‐07‐1
N‐(3‐(2‐formamido‐5‐methoxyphenyl)‐3‐oxopropyl)acetamide 52450‐38‐1
2‐(5‐methoxy‐1H‐indol‐3‐yl)ethanamine hydrochloride 66‐83‐1
Product: MELOXICAM IMPURITIES
Meloxicam EP Impurity A/ Meloxicam Related Compund A (Piroxicam EP Impurity K)
113913‐36‐3
24683‐26‐9
Meloxicam EP Impurity B/ Meloxicam Related Compund B 7305‐71‐7
Meloxicam EP Impurity C 1262333‐25‐4
Meloxicam EP Impurity D 1331636‐17‐9
47.
Meloxicam EP Impurity E (Piroxicam EP Impurity J) 35511‐15‐0
Meloxicam EP Impurity F/ Meloxicam Related Compund C (Piroxicam EP Impurity L) 118854‐48‐1
Meloxicam Related Compund D (O‐Methyl Meloxicam/ 4‐Methoxy Meloxicam)
Amido Ethyl Meloxicam 881399‐30‐0
Amido Methyl Meloxicam 892395‐41‐4
Product: MELPHALAN IMPURITIES
Melphalan EP Impurity H (Melphalan Methyl Ester) 88457‐23‐2
Melphalan Mono‐chloroethyl 573704‐41‐3
Melphalan EP Impurity D (Hydroxy Melphalan) 61733‐01‐5
Product: MEMANTINE IMPURITIES
Memantine Related Compund A (1,3‐Dimethyladamantane) 702‐79‐4
Memantine Related Compund B (3,5‐Dimethyladamantane‐1‐ol) 707‐37‐9
Memantine Related Compund C (1‐Chloro‐3,5‐dimethyladamantane) 707‐36‐8
Memantine Related Compund D (1‐Bromo‐3,5‐dimethyladamantane) 941‐37‐7
Memantine Related Compund E (N‐3,5‐Dimethyladamantan‐1‐yl formamide) 351329‐88‐9
Memantine Related Compund F
63971‐25‐5
356572‐08‐2
Memantine Related Compund G (Desmethyl Memantine) 33103‐93‐4
Amantadine Hydrochloride 665‐66‐7
N‐Acetyl Memantine 19982‐07‐1
Adamantane 281‐23‐2
Memantine N‐oxide 1262583‐10‐7
1,3,5‐Trimethyladamantane 707‐35‐7
1‐Methyl Adamantane 768‐91‐2
Product: MEPHENESIN IMPURITIES
Chlorphenesin 104‐29‐0
Product: MEPIVACAINE IMPURITIES
Mepivacaine EP Impurity A (Ropivacaine EP Impurity H/ Ropivacaine Related Compound A (Lidocaine EP Impurity A/
Lidocaine Related Compound A/ Bupivacaine EP Impurity F)
87‐62‐7
21436‐98‐6
48.
Mepivacaine EP Impurity B (Bupivacaine EP Impurity B/ Bupivacaine Related Compound B/ N‐Desbutyl Bupivacaine)
15883‐20‐2
65797‐42‐4
Mepivacaine EP Impurity C (Bupivacaine EP Impurity A) 39627‐98‐0
Product: MEPYRAMINE IMPURITIES
Mepyramine EP Impurity C (Tenoxicam EP Impurity A/ Piroxicam EP Impurity A/ 2‐Aminopyridine) 504‐29‐0
Product: MESALAMINE IMPURITIES/ MESALAZINE IMPURITIES
Mesalazine EP Impurity B 591‐27‐5
Mesalazine EP Impurity C 95‐55‐6
Mesalazine EP Impurity D 99‐05‐8
Mesalazine EP Impurity E 65‐49‐6
Mesalazine EP Impurity F 570‐23‐0
Mesalazine EP Impurity G 490‐79‐9
Mesalazine EP Impurity H (Lamivudine EP Impurity C/ Acetylsalicylic Acid EP Impurity C/ Salicylic Acid/ Sulfasalazine EP
Impurity H) 69‐72‐7
Mesalazine EP Impurity I 3147‐53‐3
Mesalazine EP Impurity J 112725‐89‐0
Mesalazine EP Impurity K (Trimethoprim EP Impurity K) 62‐53‐3
Mesalazine EP Impurity L (Mefenamic Acid EP Impurity C) 118‐91‐2
Mesalazine EP Impurity M 2516‐96‐3
Mesalazine EP Impurity N 96‐97‐9
Mesalazine EP Impurity P 887256‐40‐8
Mesalazine EP Impurity Q 3970‐35‐2
Mesalazine EP Impurity R 85‐38‐1
Mesalazine EP Impurity S 1797983‐23‐3
Mesalazine N‐Acetyl Impurity 51‐59‐2
Mesalazine N‐β‐D‐Glucoside 123135‐21‐7
Product: MESNA IMPURITIES
Mesna EP Impurity A 25985‐57‐3
Product: METAMIZOLE IMPURITIES
49.
Metamizole EP Impurity A (4‐Formylamino Antipyrine) 1672‐58‐8
Metamizole EP Impurity B (4‐Aminophenazone) 83‐07‐8
Metamizole EP Impurity C (4‐Methylamino Antipyrine)
519‐98‐2
856307‐27‐2
Metamizole EP Impurity D (4‐Dimethylamino Antipyrine) 58‐15‐1
Product: METAXALONE IMPURITIES
Metaxalone Impurity A 59365‐66‐1
Metaxalone Related Compound B 66766‐07‐2
Metaxalone Mono Impurity 1392430‐16‐8
Metaxalone Oxirane Impurity 4287‐30‐3
3,5‐Dimethylphenol 108‐68‐9
Product: METFORMIN IMPURITIES
Metformin EP Impurity A/ Metformin Related Compound A (1‐Cyanoguanidine) 461‐58‐5
Metformin EP Impurity B (Guanylmelamine)
4405‐08‐7
2959‐04‐8
Metformin EP Impurity C/ Metformin Related Compound C (1‐Cyanoguanidine) 1985‐46‐2
Metformin EP Impurity D (Melamine) 108‐78‐1
Metformin EP Impurity E/ Metformin Related Compound B (N‐Desmethyl Metformin)
1609‐00‐3
36801‐25‐9
1674‐62‐0
Metformin EP Impurity F (Imatinib EP Impurity I/ Dacarbazine EP Impurity D) 506‐59‐2
Product: METHOCARBAMOL IMPURITIES
Methocarbamol B‐Isomer 10488‐39‐8
Methocarbamol Dioxolone (rac Guaifenesin Cyclic Carbonate) 2049‐21‐0
Product: METHOTREXATE IMPURITIES
Methotrexate EP Impurity A
945‐24‐4
73978‐41‐3
Methotrexate EP Impurity D 5623‐18‐7
Methotrexate EP Impurity E 19741‐14‐1
Methotrexate EP Impurity H (Methotrexate 5‐Methyl Ester) 67022‐39‐3
50.
Methotrexate EP Impurity J (Methotrexate Dimethyl Ester) 34378‐65‐9
Methotrexate EP Impurity K (Folic Acid EP Impurity A) 4271‐30‐1
Methotrexate EP Impurity L 52980‐68‐4
Product: METHOXSALEN IMPURITIES
2‐Chloro‐1‐(2,3,4‐trihydroxyphenyl)ethan‐1‐one 17345‐68‐5
3‐Bromophthalide 6940‐49‐4
6,7‐Dihydroxycoumeranone 6272‐27‐1
4',5'‐Dihydro‐8‐hydroxypsoralen 68123‐30‐8
4',5'‐Dihydro‐8‐methoxypsoralen .3779‐03‐1
Product: METHYLPREDNISOLONE IMPURITIES
Methylprednisolone Acetate EP Impurity E (Hydrocortisone Acetate EP Impurity C/ Prednisolone EP Impurity C) 52‐21‐1
Product: METOCLOPRAMIDE IMPURITIES
Metoclopramide EP Impurity A/ Metoclopramide Related Compound A (N‐Acetyl Metoclopramide) 5608‐13‐9
Metoclopramide EP Impurity E 100‐36‐7
Metoclopramide EP Impurity F (O‐Desmethyl Metoclopramide)
38339‐95‐6
38059‐78‐8
Metoclopramide EP Impurity G (Metoclopramide N‐Oxide) 171367‐22‐9
Metoclopramide EP Impurity H 50‐86‐2
Product: METOLAZONE IMPURITIES
Metolazone EP Impurity A 50869‐25‐5
Metolazone EP Impurity B 28508‐63‐6
Metolazone EP Impurity C (Desmethyl Metolazone) 28524‐40‐5
Metolazone EP Impurity D (3,4‐Didehydro Metolazone) 4015‐23‐0
Metolazone EP Impurity E (Metolazone Benzamide Analog) 23380‐54‐3